To easily search for a policy, use the Ctrl+F (Command+F on Mac) function on your keyboard to search by keyword, policy number or effective date. 

What are Clinical Policies?

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include policies relating to evolving medical technologies and procedures as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice, including peer-reviewed medical literature, government agency/program approval status, evidence-based guidelines, positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas affected by the policy, and other available clinical information.

All policies found on the QualChoice Clinical Policy page apply to QualChoice members. Policies on this QualChoice page may have either a “QualChoice” or a “Centene” heading. QualChoice follows care guidelines published by InterQual.
QualChoice may, from time to time, delegate utilization management of specific services. In such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the policies on this page or within the InterQual criteria is payable by QualChoice.

QualChoice reserves the right to alter, amend, change or supplement medical policies as needed. QualChoice reviews and authorizes services and substances. CPT and HCPCS codes are listed as a convenience and any absent, new or changed codes do not alter the intent of the policy.

What are Payment Policies?

Healthcare claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether healthcare services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include claims processing guidelines referenced by the Centers for Medicare & Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), CPT® guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of healthcare and medical necessity, ClaimsXten™ review, and, at times, state-specific claims reimbursement guidance. More information about ClaimsXten and the way we utilize ClaimsXten with relation to claims payments can be found on our Claims and Payment Information page.

All policies found on this page apply with respect to QualChoice members. These payment policies may have either a “QualChoice” or a “Centene” heading. QualChoice may, from time-to-time, employ a vendor that applies payment policies to specific services. In such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in these policies is payable by QualChoice.

Clinical Policies for CT/CTA/CCTA, MRI, MRA, and Pet scans can also be found at the Evolent website.

   
Policy Title Policy Number Effective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF) CP.MP.157 November 1, 2024
Air Ambulance (PDF) CP.MP.175 July 1, 2024
Ambulance Services QCP.CP.045 May 1, 2024
Allergy Testing & Treatment (PDF) CP.MP.100 November 1, 2024
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF) CP.MP.108 October 1, 2024
Alternative or Complementary Healing (PDF) QCP.CP.018 May 1, 2024
Applied Behavioral Analysis (PDF) CP.BH.104 May 1, 2024
Assisted Reproductive Technology (PDF) CP.MP.55 May 1, 2024
Attention Deficit Hyperactivity Disorder Assessment and Treatment (PDF) CP.BH.124 May 1, 2024
Bariatric Surgery: Federal Employees Health Benefits (PDF) QCP.CP.029 May 1, 2024
Behavioral Health Treatment Documentation Requirements (PDF) CP.BH.500 July 1, 2024
Biofeedback (PDF) CP.MP.168 February 1, 2025
Biofeedback for Behavioral Health Disorders (PDF) CP.BH.300 January 1, 2025
Bone-Anchored Hearing Aids (PDF) AR.CP.MP.93 January 1, 2025
Burn Surgery (PDF) CP.MP.186 February 1, 2025
Cardiac Biomarker Testing (PDF) CP.MP.156 November 1, 2024
Caudal or Interlaminar Epidural Steroid Injections (PDF) CP.MP.164 August 1, 2024
Clinical Trials (PDF) CP.MP.94 August 1, 2024
Cochlear Implanted Replacements (PDF) AR.CP.MP.14 September 1, 2024
Concert Genetics Oncology: Algorithmic Testing (PDF) V2.2024 September 1, 2024
Concert Genetics Oncology: Cancer Screening (PDF) V2.2024 September 1, 2024
Concert Genetics Oncology: Circulating Tumor DNA and Circulating
Tumor Cells (Liquid Biopsy) (PDF)
V2.2024 September 1, 2024
Concert Genetics Oncology: Cytogenetic Testing (PDF) V2.2024  September 1, 2024
Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF) V2.2024   September 1, 2024
Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Cardiac Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Dermatologic Conditions (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Eye Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: General Approach to Genetic Testing (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Hearing Loss (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Hematologic Conditions (non-cancerous) (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Hereditary Cancer Susceptibility (PDF) CG2025.1 March 1, 2025
Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Kidney Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Lung Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Non-invasive Prenatal Screening (NIPS) (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Pharmacogenetics (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Preimplantation Genetic Testing (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Prenatal and Preconception Carrier Screening (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF) V2.2024 September 1, 2024
Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF) V2.2024 September 1, 2024
Corneal Remodeling (f.n.a. Refractive Surgical Procedures) (PDF) QCP.CP.021 May 1, 2024
Corneal Topography (PDF) QCP.CP.022 May 1, 2024
Cosmetic and Reconstructive Procedures (PDF) CP.MP.31 October 1, 2024
Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF) CP.BH.201 August 1, 2024
Diaphragmatic/Phrenic Nerve Stimulation (PDF) CP.MP.203 September 1, 2024
Digital EEG Spike Analysis (PDF) CP.MP.105 November 1, 2024
Disc Decompression Procedures (PDF) CP.MP.114 October 1, 2024
Discography (PDF) CP.MP.115 July 1, 2024
Donor Lymphocyte Infusion (PDF) CP.MP.101 June 1, 2024
Drugs of Abuse, Definitive Testing (PDF) CP.MP.50 November 1, 2024
Durable Medical Equipment and Orthotics Guidelines (PDF) AR.CP.MP.107 November 1, 2024
EED in the Evaluation of Headache (PDF) CP.MP.155 November 1, 2024
Electric Tumor Treating Fields (Optune) (PDF) CP.MP.145 March 1, 2025
Endometrial Ablation (PDF) CP.MP.106 November 1, 2024
Evoked Potential Testing (PDF) CP.MP.134 November 1, 2024
Experimental Technologies (PDF) CP.MP.36 June 1, 2024
Facet Joint Interventions (PDF) CP.MP.171 November 1, 2024
Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF) CP.MP.248 March 1, 2025
Fecal Incontinence Treatments (PDF) CP.MP.137 August 1, 2024
FEHB Fertility Preservation (PDF) QCP.CP.042 May 1, 2024
FEHBP Gender Reassignment Surgery (PDF) QCP.CP.037 May 1, 2024
FEHB Infertility Coverage (PDF) QCP.CP.027 May 1, 2024
Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF) CP.MP.129 November 1, 2024
Ferriscan R2-MRI (PDF) CP.MP.53 May 1, 2024
Functional MRI (PDF) CP.MP.43 May 1, 2024
Gastric Electrical Stimulation (PDF) CP.MP.40 May 1, 2024
Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (PDF) CP.MP.209 May 1, 2024
Gender Affirming Procedures (PDF) CP.MP.95 September 1, 2024
H. Pylori Serology Testing (PDF) CP.MP.153 November 1, 2024
Habilitative Services (PDF) QCP.CP.035 May 1, 2024
Heart-Lung Transplant (PDF) CP.MP.132 May 1, 2024
Holter Monitors (PDF) CP.MP.113 May 1, 2024
Home Ventilators (PDF) CP.MP.184 October 1, 2024
Hospice Services (PDF) CP.MP.54 November 1, 2024
Hyperhidrosis Treatments (PDF) CP.MP.62 June 1, 2024
Hypnotherapy (PDF) QCP.CP.014 May 1, 2024
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF) CP.MP.180 January 1, 2025
Implantable Intrathecal or Epidural Pain Pump (PDF) CP.MP.173 February 1, 2025
Implantable Loop Recorder (PDF) CP.MP.243 February 1, 2025
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF) CP.MP.160 June 1, 2024
Infertility Diagnosis and Treatment (PDF) QCP.CP.015 May 1, 2024
Intensity-Modulated Radiotherapy (PDF) CP.MP.69 September 1, 2024
Intestinal and Multivisceral Transplant (PDF) CP.MP.58 July 1, 2024
Intradiscal Steroid Injections for Pain Management (PDF) CP.MP.167 September 1, 2024
Intraoperative Neurophysiological Monitoring (PDF) QCP.CP.033 May 1, 2024
IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (PDF) CP.MP.61 October 1, 2024
Lantidra (donislecel) Allogenic Pancreatic Islet Cellular Therapy (PDF) CP.MP.250 September 1, 2024
Liposuction for Lipedema (PDF) CP.MP.244 July 1, 2024
Lung Transplantation (PDF) CP.MP.57 June 1, 2024
Lysis of Epidural Lesions (PDF) CP.MP.116 July 1, 2024
Measurement of Serum 1,25-dihydroxyvitamin D (PDF) CP.MP.152 November 1, 2024
Mechanical Stretch devices for joint stiffness or contractures (PDF) CP.MP.144 December 1, 2024
Medical Services that Require Dental Services (PDF) QCP.CP.030 May 1, 2024
Multiple Sleep Latency Testing (PDF) CP.MP.24 July 1, 2024
Neonatal Abstinence Syndrome Guidelines (PDF) CP.MP.86 May 1, 2024
Neonatal Sepsis Management (PDF) CP.MP.85 May 1, 2024
Nerve Blocks for Pain Management (PDF) CP.MP.170 June 1, 2024
Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF) CP.MP.48 August 1, 2024
NICU Apnea Bradycardia Guidelines (PDF) CP.MP.82 May 1, 2024
NICU Discharge Guidelines (PDF) CP.MP.81 May 1, 2024
Nonmyeloablative Allogeneic Stem Cell Transplants (PDF) CP.MP.141 May 1, 2024
Obesity Management & Bariatric Surgery (PDF) QCP.CP.041 May 1, 2024
Obstetrical Home Care Programs (PDF) CP.MP.91 February 1, 2025
Omisirge (omidubicel): Nicotinamide-modified allogeneic hematopoietic progenitor cell therapy (PDF) CP.MP.249 August 1, 2024
Orthognathic Surgery (PDF) CP.MP.202  October 1, 2024
Osteogenic Stimulation (PDF) CP.MP.194 September 1, 2024
Pancreas Transplantation (PDF) CP.MP.102 May 1, 2024
Panniculectomy (PDF) CP.MP.109 October 1, 2024
Pediatric Heart Transplant (PDF) CP.MP.138 October 1, 2024
Pediatric Kidney Transplant (PDF) CP.MP.246 June 1, 2024
Pediatric Liver Transplant (PDF) CP.MP.120 July 1, 2024
Pediatric Oral Function Therapy (PDF) CP.MP.188 July 1, 2024
Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF) CP.MP.147 July 1, 2024
Phototherapy for Neonatal Hyperbilirubinemia (PDF) CP.MP.150 March 1, 2025
Physical, Occupational, and Speech Therapy Services (PDF) CP.MP.49 August 1, 2024
PPO Infertility Treatment (PDF) QCP.CP.031 May 1, 2024
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF) CP.MP.181 May 1, 2024
Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF) CP.MP.133 September 1, 2024
Prosthetics (PDF) QCP.CP.028 May 1, 2024
Proton and Neutron Beam Therapies (PDF) CP.MP.70 May 1, 2024
Reduction Mammoplasty and Gynecomastia Surgery (PDF) CP.MP.51 November 1, 2024
Repair of Nasal Valve Compromise (PDF) CP.MP.210 July 1, 2024
Sacroiliac Joint Fusion (PDF) CP.MP.126 October 1, 2024
Sacroiliac Joint Interventions for Pain Management (PDF) CP.MP.166 September 1, 2024
Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF) CP.MP.146 September 1, 2024
Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF) CP.MP.174 February 1, 2025
Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF) CP.MP.165 September 1, 2024
Skin and Soft Tissue Substitutes for Chronic Wounds (PDF) CP.MP.185 August 1, 2024
Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF) CP.MP.117 February 1, 2025
Stereotactic Body Radiation Therapy (PDF) CP.MP.22 December 1, 2024
Substance Use Disorders Treatment and Services (PDF) CP.BH.100 May 1, 2024
Tandem Transplant (PDF) CP.MP.162 May 1, 2024
Testing for Select Genitourinary Conditions (PDF) CP.MP.97 May 1, 2024
Therapeutic Utilization of Inhaled Nitric Oxide (PDF) CP.MP.87 February 1, 2025
Thyroid Hormones and Insulin Testing in Pediatrics (PDF) CP.MP.154 November 1, 2024
TMJ Coverage (PDF) QCP.CP.026 May 1, 2024
Total Artificial Heart (PDF) CP.MP.127 August 1, 2024
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF) CP.MP.163 May 1, 2024
Transplant Service Documentation Requirements (PDF) CP.MP.247 December 1, 2024
Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (PDF) CP.BH.200 August 1, 2024
Trigger Point Injections for Pain Management (PDF) CP.MP.169 September 1, 2024
Urinary Incontinence Devices and Treatments (PDF) CP.MP.142 May 1, 2024
Vagus Nerve Stimulation (PDF) CP.MP.12 February 1, 2025
Ventricular Assist Devices (PDF) CP.MP.46 February 1, 2025
Wireless Motility Capsule (PDF) CP.MP.143 November 1, 2024
Policy Title Policy Number Effective Date
3-Day Payment Window (PDF) CC.PP.500 May 1, 2024
Add-On Code Billed Without Primary Code (PDF) CC.PP.030 May 1, 2024
Ambulatory EEG (PDF) CP.MP.96 May 1, 2024
Assistant Surgeon (PDF) CC.PP.029 May 1, 2024
Autism Spectrum Disorder Treatment QCP.CP.044 May 1, 2024
Bronchial Thermoplasty (PDF) CP.MP.110 November 1, 2023
Clean Claims (PDF) CC.PP.021 May 1, 2024
Coding Overview (PDF) CC.PP.011 May 1, 2024
Cosmetic Procedures (PDF) CC.PP.024 May 1, 2024
E&M Medical Decision-Making (PDF) CC.PP.051 May 1, 2024
Emergency Department Care QCP.PP.040 May 1, 2024
Global Maternity Billing (PDF) CC.PP.016 May 1, 2024
Hospice Services (PDF) CP.MP.54 May 1, 2024
Inpatient Consultation (PDF) CC.PP.038 May 1, 2024
Inpatient Only Procedures (PDF) MP.PP.018 May 1, 2024
Laser Therapy for Skin Conditions (PDF) CP.MP.123 November 1, 2024
Low-frequency Ultrasound and Noncontact Normothermic Wound Therapy (PDF) CP.MP.139 November 1, 2024
Maximum Units (PDF) CC.PP.007 May 1, 2024
Moderate Conscious Sedation (PDF) CC.PP.015 May 1, 2024
Modifier DOS Validation (PDF) CC.PP.034 May 1, 2024
Modifier to Procedure Code Validation (PDF) CC.PP.028 May 1, 2024
Multiple CPT Code Replacement (PDF) CC.PP.033 May 1, 2024
NCCI Unbundling (PDF) CC.PP.031 May 1, 2024
Never Paid Events (PDF) CC.PP.017 May 1, 2024
Non Face-to-Face Services (PDF) QCP.PP.017 May 1, 2024
Outpatient Consultation (PDF) CC.PP.039 May 1, 2024
Pediatric Dental (PDF) QCP.PP.036 May 1, 2024
Physician Extenders (PDF) QCP.PP.032 May 1, 2024
Place of Service Mismatch (PDF) CC.PP.063  May 1, 2024
Platelet Rich Plasma (PDF) QCP.PP.010 May 1, 2024
Post-Operative Visits (PDF) CC.PP.042 May 1, 2024
Pre-Operative Visits (PDF) CC.PP.041 May 1, 2024
Preventive Health Benefit (PDF) QCP.PP.016 May 1, 2024
Problem Oriented Visits with Preventative Services (PDF) CC.PP.057 May 1, 2024
Prolonged Medical Services (PDF) QCP.PP.013 May 1, 2024
Pulmonary Function Testing (PDF) CP.MP.242 November 1, 2024
Pulse Oximetry (PDF) CC.PP.025 May 1, 2024
Robotic Surgery (PDF) CC.PP.050 May 1, 2024
Routine & Complex Office Procedures (PDF) QCP.PP.025 May 1, 2024
Same Day Visits (PDF) CC.PP.040 May 1, 2024
Severe Malnutrition (PDF) CC.PP.145 November 1, 2024
Sex Assignment (PDF) QCP.PP.012 May 1, 2024
Skilled Nursing Facility Leveling (PDF) CC.PP.206 October 1, 2024
Status "B" Bundled Services (PDF) CC.PP.046 May 1, 2024
Status P Bundled Services (PDF) CC.PP.049 May 1, 2024
Sterilization (PDF) QCP.PP.008 May 1, 2024
Supplies Billed on Same Day As Surgery (PDF) CC.PP.032 May 1, 2024
Transgender Related Services (PDF) CC.PP.047 May 1, 2024
Ultrasound in Pregnancy (PDF) CP.MP.38 November 1, 2024
Unbundled Professional Services (PDF) CC.PP.043 May 1, 2024
Unlisted Procedure Codes (PDF) CC.PP.009 May 1, 2024
Urine Specimen Validity Testing (PDF) CC.PP.056 May 1, 2024
Urodynamic Testing (PDF) CP.MP.98 November 1, 2024
Women's Preventive Health Care - Contraception (PDF) QCP.PP.011 May 1, 2024
 
Policy Title Policy Number Effective Date
Abaloparatide (Tymlos) (PDF) CP.PHAR.345 Retire by April 1, 2025
Abaloparatide (Tymlos) (PDF)  CP.PHAR.345  April 1, 2025
Abatacept (Orencia) (PDF) CP.PHAR.241 January 1, 2025
Abemaciclib (Verzenio) (PDF) CP.PHAR.355 January 1, 2025
Abiraterone (Zytiga) (PDF) CP.PHAR.84 Retire by April 1, 2025
Abiraterone (Zytiga) (PDF)  CP.PHAR.84  April 1, 2025
AbobotulinumtoxinA (Dysport) (PDF) CP.PHAR.230 June 1, 2024
Abrocitinib (Cibinqo) (PDF) CP.PHAR.578 January 1, 2025
Acalabrutinib (Calquence) (PDF) CP.PHAR.366 Retire by June 1, 2025
Acalabrutinib (Calquence) (PDF)  CP.PHAR.366 June 1, 2025
Acoramidis (Attruby) (PDF) CP.PHAR.683 April 1, 2025
Acyclovir Buccal tab (Sitavig) (PDF) CP.PMN.210 January 1, 2025
Adagrasib (Krazati) (PDF) CP.PHAR.605 Retire by June 1, 2025
Adagrasib (Krazati) (PDF)  CP.PHAR.605  June 1, 2025
ADAMTS13, recombinant-krhn (Adzynma) (PDF) CP.PHAR.635 Retire by April 1, 2025
ADAMTS13, recombinant-krhn (Adzynma) (PDF)  CP.PHAR.635  April 1, 2025
Adefovir (Hepsera) (PDF) CP.PHAR.142 January 1, 2025
Ado-Trastuzumab Emtansine (Kadcyla) (PDF) CP.PHAR.229 June 1, 2024
Aducanumab-avwa (Aduhelm) (PDF) CP.PHAR.468 June 1, 2024
Afamelanotide (Scenesse) (PDF) CP.PHAR.444 Retire by April 1, 2025
Afamelanotide (Scenesse) (PDF)  CP.PHAR.444  April 1, 2025
Afamitresgene Autoleucel (Tecelra) (PDF) CP.PHAR.678 January 1, 2025
Afatinib (Gilotrif) (PDF) CP.PHAR.298 January 1, 2025
Aflibercept (Eylea, Eylea HD) (PDF) CP.PHAR.184 Retire by April 1, 2025
Aflibercept (Eylea, Eylea HD) (PDF)  CP.PHAR.184  April 1, 2025
Agalsidase Beta (Fabrazyme) (PDF) CP.PHAR.158 July 1, 2024
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF) CP.PMN.138 January 1, 2025
Alectinib (Alecensa) (PDF) CP.PHAR.369 January 1, 2025
Alemtuzumab (Lemtrada) (PDF) CP.PHAR.243 June 1, 2024
Alendronate (Binosto, Fosamax plus D) (PDF) CP.PMN.88 Retire by April 1, 2025
Alendronate (Binosto, Fosamax plus D) (PDF)  CP.PMN.88  April 1, 2025
Alglucosidase Alfa (Lumizyme) (PDF) CP.PHAR.160 Retire by April 1, 2025
Alglucosidase Alfa (Lumizyme) (PDF)  CP.PHAR.160  April 1, 2025
Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF) CP.PHAR.562 Retire by April 1, 2025
Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF)   CP.PHAR.562  April 1, 2025
Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF) CP.PHAR.563 Retire by April 1, 2025
Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF)  CP.PHAR.563  April 1, 2025
Alpelisib (Piqray) (PDF) CP.PHAR.430 January 1, 2025
Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF) CP.PHAR.94 Retire by April 1, 2025
Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF)   CP.PHAR.94  April 1, 2025
Amantadine ER (Gocovri,Osmolex ER) (PDF) CP.PMN.89 Retire by April 1, 2025
Amantadine ER (Gocovri,Osmolex ER) (PDF)  CP.PMN.89  April 1, 2025
Ambrisentan (Letairis®) (PDF) CP.PHAR.190 Retire by April 1, 2025
Ambrisentan (Letairis®) (PDF)  CP.PHAR.190  April 1, 2025
Amifampridine (Firdapse)(PDF) CP.PHAR.411 Retire by April 1, 2025
Amifampridine (Firdapse)(PDF)  CP.PHAR.411  April 1, 2025
Amikacin (Arikayce)(PDF) CP.PHAR.401 January 1, 2025
Amisulpride (Barhemsys) (PDF)  CP.PMN.236 October 1, 2024
Amivantamab-vmjw (Rybrevant) (PDF) CP.PHAR.544 January 1, 2025
Anifrolumab-fnia (Saphnelo) (PDF) CP.PHAR.551 March 1, 2025
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF) CP.PHAR.217 Retire by April 1, 2025
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF)  CP.PHAR.217  April 1, 2025
Antithrombin III (ATryn, Thrombate III) (PDF) CP.PHAR.564 Retire by April 1, 2025
Antithrombin III (ATryn, Thrombate III) (PDF)  CP.PHAR.564  April 1, 2025
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) CP.PHAR.506 January 1, 2025
Apalutamide (Erleada) (PDF) CP.PCH.45 January 1, 2025
Apomorphine (Apokyn) (PDF) CP.PHAR.488 January 1, 2025
Aprepitant (Emend®) (PDF) CP.PMN.19 January 1, 2025
Aprocitentan (Tryvio) (PDF) CP.PHAR.676 January 1, 2025
Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (PDF) CP.PHAR.290 May 1, 2024
Aripiprazole ODT (Abilify) (PDF) CP.PCH.37 Retire by April 1, 2025
Aripiprazole Orally Disintegrating Tablet, Oral Film (Opipza) (PDF)  CP.PMN.300 April 1, 2025
Armodafinil (Nuvigil) (PDF) CP.PMN.35 January 1, 2025
Asciminib (Scemblix) (PDF) CP.PHAR.565 Retire by June 1, 2025
Asciminib (Scemblix) (PDF)  CP.PHAR.565  June 1, 2025
Asenapine (Saphris, Secuado) (PDF) CP.PMN.15 January 1, 2025
Asfotase Alfa (Strensiq) (PDF) CP.PHAR.328 January 1, 2025
Aspirin-dipyridamole (Aggrenox) (PDF) CP.PMN.20 Retire by April 1, 2025
Aspirin-dipyridamole (Aggrenox) (PDF)  CP.PMN.20  April 1, 2025
Atezolizumab (Tecentriq) (PDF) CP.PHAR.235 Retire by June 1, 2025
Atezolizumab (Tecentriq) (PDF)  CP.PHAR.235  June 1, 2025
Atidarsagene autotemcel (Lenmeldy) (PDF) CP.PHAR.602 Retire by April 1, 2025
Atidarsagene autotemcel (Lenmeldy) (PDF)  CP.PHAR.602  April 1, 2025
Atogepant (Qulipta) (PDF) CP.PHAR.566 January 1, 2025
Avacincaptad pegol (Izervay) (PDF) CP.PHAR.641 March 1, 2025
Avacopan (Tavneos) (PDF) CP.PHAR.515 Retire by April 1, 2025
Avacopan (Tavneos) (PDF)  CP.PHAR.515  April 1, 2025
Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF) CP.PHAR.521 Retire by April 1, 2025
Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF)  CP.PHAR.521  April 1, 2025
Avapritinib (Ayvakit) (PDF) CP.PHAR.454 Retire by April 1, 2025
Avapritinib (Ayvakit) (PDF)  CP.PHAR.454  April 1, 2025
Avatrombopag (Doptelet) (PDF) CP.PHAR.130 January 1, 2025
Avelumab (Bavencio) (PDF) CP.PHAR.333 Retire by April 1, 2025
Avelumab (Bavencio) (PDF)  CP.PHAR.333  April 1, 2025
Axatilimab-csfr (Niktimvo) (PDF) CP.PHAR.691 January 1, 2025
Axicabtagene Ciloleucel (Yescarta) (PDF) CP.PHAR.362 Retire by June 1, 2025
Axicabtagene Ciloleucel (Yescarta) (PDF)  CP.PHAR.362  June 1, 2025
Axitinib (Inlyta) (PDF) CP.PHAR.100 Retire by April 1, 2025
Axitinib (Inlyta) (PDF)  CP.PHAR.100 April 1, 2025
Azacitidine (Onureg, Vidaza) (PDF) CP.PHAR.387 March 1, 2025
Azelaic Acid (Finacea) (PDF) HIM.PA.119 January 1, 2025
Aztreonam (Cayston) (PDF) CP.PHAR.209 January 1, 2025
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) CP.PHAR.149 January 1, 2025
Baloxavir Marboxil (Xofluza) (PDF) CP.PMN.185 January 1, 2025
Bedaquiline (Sirturo) (PDF) CP.PMN.212 Retire by April 1, 2025
Bedaquiline (Sirturo) (PDF)  CP.PMN.212  April 1, 2025
Belantamab Mafodotin-blmf (Blenrep) (PDF) CP.PHAR.469 June 1, 2024
Belatacept (Nulojix) (PDF) CP.PHAR.201 January 1, 2025
Belimumab (Benlysta) (PDF) CP.PHAR.88 October 1, 2024
Belinostat (Beleodaq) (PDF) CP.PHAR.311 March 1, 2025
Belumosudil (Rezurock) (PDF) CP.PHAR.552 January 1, 2025
Belzutifan (Welireg) (PDF) CP.PHAR.553 January 1, 2025
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF) CP.PMN.237 Retire by April 1, 2025
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF)  CP.PMN.237  April 1, 2025
Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) CP.PHAR.307 March 1, 2025
Benralizumab (Fasenra) (PDF) HIM.PA.SP70 March 1, 2025
Benznidazole (PDF) CP.PMN.90 Retire by April 1, 2025
Benznidazole (PDF)  CP.PMN.90  April 1, 2025
Berdazimer (Zelsuvmi) (PDF) CP.PMN.293 January 1, 2025
Beremagene geperpavec-svdt (Vyjuvek) (PDF) CP.PHAR.592 September 1, 2024
Berotralstat (Orladeyo) (PDF) HIM.PA.169 January 1, 2025
Betaine (Cystadane) (PDF) CP.PHAR.143 January 1, 2025
Betamethasone Dipropionate Spray (Sernivo) (PDF) CP.PMN.182 January 1, 2025
Betibeglogene Autotemcel (Zynteglo) (PDF)  CP.PHAR.545 October 1, 2024
Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) (PDF) CP.PHAR.93 March 1, 2025
Bexarotene (Targretin) (PDF) CP.PHAR.75 January 1, 2025
Bezlotoxumab (Zinplava) (PDF) CP.PHAR.300 Retire by April 1, 2025
Bezlotoxumab (Zinplava) (PDF)  CP.PHAR.300  April 1, 2025
Bimatoprost Implant (Durysta) (PDF) CP.PHAR.486 June 1, 2024
Binimetinib (Mektovi) (PDF) CP.PHAR.50 January 1, 2025
Biologic and Non-biologic DMARDs (PDF) HIM.PA.SP60 Retire by April 1, 2025
Biologic and Non-biologic DMARDs (PDF)  HIM.PA.SP60  April 1, 2025
Birch Triterpenes (Filsuvez) (PDF) CP.PHAR.669 Retire by June 1, 2025
Birch Triterpenes (Filsuvez) (PDF)  CP.PHAR.669  June 1, 2025
Blinatumomab (Blincyto) (PDF)  CP.PHAR.312 November 1, 2024
Bortezomib (Velcade) (PDF) CP.PHAR.410 Retire by April 1, 2025
Bortezomib (Velcade) (PDF)  CP.PHAR.410  April 1, 2025
Bosentan (Tracleer®) (PDF) CP.PHAR.191 Retire by April 1, 2025
Bosentan (Tracleer®) (PDF)  CP.PHAR.191  April 1, 2025
Bosutinib (Bosulif) (PDF) CP.PHAR.105 January 1, 2025
Brand Name Override and Non-Formulary Medications (PDF) HIM.PA.103 January 1, 2025
Brentuximab Vedotin (Adcetris) (PDF)  CP.PHAR.303 October 1, 2024
Brexanolone (Zulresso) (PDF) CP.PHAR.417 June 1, 2024
Brexpiprazole (Rexulti) (PDF) CP.PMN.68 January 1, 2025
Brexucabtagene Autoleucel (Tecartus) (PDF) CP.PHAR.472 Retire by April 1, 2025
Brexucabtagene Autoleucel (Tecartus) (PDF)  CP.PHAR.472  April 1, 2025
Brigatinib (Alunbrig) (PDF) CP.PHAR.342 January 1, 2025
Brimonidine Tartrate (Mirvaso) (PDF) CP.PMN.192 January 1, 2025
Brinzolamide/Brimonidine (Simbrinza) (PDF) HIM.PA.15 January 1, 2025
Brivaracetam (Briviact) (PDF) CP.PMN.297 January 1, 2025
Brolucizumab-dbll (Beovu) (PDF) CP.PHAR.445 Retire by June 1, 2025
Brolucizumab-dbll (Beovu) (PDF)  CP.PHAR.445  June 1, 2025
Budesonide (Eohilia, Uceris) (PDF) CP.PMN.294 January 1, 2025
Budesonide (Tarpeyo) (PDF) CP.PHAR.572 Retire by April 1, 2025
Budesonide (Tarpeyo) (PDF)  CP.PHAR.572  April 1, 2025
Bupropion/Naltrexone (Contr07e) (PDF) CP.PCH.12 January 1, 2025
Burosumab-twza (Crysvita) (PDF) CP.PHAR.11 May 1, 2024
Butorphanol Nasal Spray (PDF) HIM.PA.46 January 1, 2025
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF) HIM.PA.170 September 1, 2024
Cabazitaxel (Jevtana) (PDF) CP.PHAR.316 June 1, 2024
Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF) CP.PHAR.573 Retire by April 1, 2025
Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF)   CP.PHAR.573  April 1, 2025
Cabozantinib (Cometriq®, Cabometyx®) (PDF) CP.PHAR.111 Retire by April 1, 2025
Cabozantinib (Cometriq®, Cabometyx®) (PDF)  CP.PHAR.111 April 1, 2025
Calcifediol (Rayaldee) (PDF) CP.PMN.76 January 1, 2025
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) CP.PMN.181 January 1, 2025
Canakinumab (Ilaris) (PDF) CP.PHAR.246 July 1, 2024
Cannabidiol (Epidiolex) (PDF) CP.PMN.164 January 1, 2025
Capecitabine (Xeloda) (PDF) CP.PHAR.60 January 1, 2025
Capivasertib (Truqap) (PDF) CP.PHAR.663 Retire by April 1, 2025
Capivasertib (Truqap) (PDF)  CP.PHAR.663  April 1, 2025
Caplacizumab-yhdp (Cablivi) (PDF) CP.PHAR.416 June 1, 2024
Capmatinib (Tabrecta) (PDF) CP.PHAR.494 January 1, 2025
CarbidopaLevodopa (Crexont, Rytary,Duopa, Dhivy), FoscarbidopaLevodopa (Vyalev) (PDF) CP.PMN.238 January 1, 2025
Carfilzomib (Kyprolis) (PDF) CP.PHAR.309 March 1, 2025
Carglumic acid (Carbaglu®) (PDF) CP.PHAR.206 Retire by June 1, 2025
Carglumic acid (Carbaglu®) (PDF)  CP.PHAR.206  June 1, 2025
Cariprazine (Vraylar) (PDF) CP.PMN.91 January 1, 2025
Casimersen (Amondys 45) (PDF) CP.PHAR.470 Retire by April 1, 2025
Casimersen (Amondys 45) (PDF)  CP.PHAR.470  April 1, 2025
Cemiplimab-rwlc (Libtayo) (PDF) CP.PHAR.397 January1, 2025
Cenegermin-bkbj (Oxervate)(PDF) CP.PMN.186 Retire by April 1, 2025
Cenegermin-bkbj (Oxervate)(PDF)  CP.PMN.186  April 1, 2025
Cenobamate (Xcopri) (PDF) CP.PMN.231 Retire by April 1, 2025
Cenobamate (Xcopri) (PDF)  CP.PMN.231  April 1, 2025
Ceritinib (Zykadia) (PDF) CP.PHAR.349 January 1, 2025
Cerliponase alfa (Brineura) (PDF) CP.PHAR.338 October 1, 2024
Cetuximab (Erbitux) (PDF) CP.PHAR.317 March 1, 2025
Chenodiol (Chenodal) (PDF) CP.PMN.239 January 1, 2025
Chlorambucil (Leukeran) (PDF) CP.PHAR.554 January 1, 2025
Chloramphenicol Sodium Succinate (PDF) CP.PHAR.388 September 1, 2024
Cholic Acid (Cholbam) (PDF) CP.PHAR.390 January 1, 2025
Ciclopirox (Penlac) (PDF) CP.PMN.24 Retire by April 1, 2025
Ciclopirox (Penlac) (PDF)  CP.PMN.24  April 1, 2025
Ciltacabtagene Autoleucel (Carvykti) (PDF) CP.PHAR.533 January 1, 2025
Cinacalcet (Sensipar) (PDF) CP.PHAR.61 January 1, 2025
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF) CP.PHAR.567 Retire by April 1, 2025
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF)  CP.PHAR.567  April 1, 2025
Ciprofloxacin/Fluocinolone (Otovel) (PDF) CP.PMN.249 January 1, 2025
Ciprofloxacin-Dexamethasone (Ciprodex) (PDF) CP.PMN.248 January 1, 2025
Cladribine (Mavenclad) (PDF) CP.PHAR.422 January 1, 2025
Clascoterone (Winlevi) (PDF) CP.PMN.257 Retire by April 1, 2025
Clascoterone (Winlevi) (PDF)  CP.PMN.257  April 1, 2025
Clobazam (Onfi) (PDF) CP.PMN.54 January 1, 2025
CNS Stimulants (PDF) CP.PMN.92 Retire by June 1, 2025
CNS Stimulants (PDF)  CP.PMN.92 June 1, 2025
Cobimetinib (Cotellic) (PDF) CP.PHAR.380 January 1, 2025
Colchicine (Colcrys, Lodoco) (PDF) CP.PMN.123 Retire by April 1, 2025
Colchicine (Colcrys, Lodoco) (PDF)  CP.PMN.123  April 1, 2025
Colesevelam (Welchol) (PDF) CP.PMN.250 January 1, 2025
Collagenase Clostridium Histolyticum (Xiaflex) (PDF) CP.PHAR.82 September 1, 2024
Colonoscopy Preparation Products (PDF) CP.PCH.43 January 1, 2025
Compounded Medications (PDF) CP.PMN.280 January 1, 2025
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF) CP.PMN.258 Retire by April 1, 2025
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF)  CP.PMN.258  April 1, 2025
Continuous Glucose Monitors (PDF) AR.QC.PMN.214 January 1, 2025 
Copanlisib (Aliqopa) (PDF) CP.PHAR.357 March 1, 2025
Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF) CP.PHAR.385 November 1, 2024
Cosibelimab-Ipdl (Unloxcyt) (PDF) CP.PHAR.711 April 1, 2025
Cosyntropin (Cortrosyn) (PDF) CP.PHAR.203 Retire by June 1, 2025
Cosyntropin (Cortrosyn) (PDF)  CP.PHAR.203  June 1, 2025
Crinecerfont (Crenessity) (PDF) CP.PHAR.692 April 1, 2025
Crisaborole (Eucrisa) (PDF) CP.PMN.110 January 1, 2025
Crizanlizumab-tmca (Adakveo) (PDF) CP.PHAR.449 Retire by April 1, 2025
Crizanlizumab-tmca (Adakveo) (PDF)  CP.PHAR.449  April 1, 2025
Crizotinib (Xalkori) (PDF) CP.PHAR.90 January 1, 2025
Crovalimab (PiaSky) (PDF) CP.PHAR.664 Retire by April 1, 2025
Crovalimab (PiaSky) (PDF)  CP.PHAR.664  April 1, 2025
Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF) CP.PMN.48 January 1, 2025
Cysteamine ophthalmic (Cystaran) (PDF) CP.PMN.130 January 1, 2025
Cysteamine oral (Cystagon, Procysbi) (PDF) CP.PHAR.155 January 1, 2025
Cytomegalovirus Immune Globulin (Cytogam) (PDF) CP.PHAR.277 September 1, 2024
Dabrafenib (Tafinlar) (PDF) CP.PHAR.239 January 1, 2025
Dacomitinib (Vizimpro) (PDF) CP.PHAR.399 January 1, 2025
Dalfampridine (Ampyra) (PDF) CP.PHAR.248 January 1, 2025
Dalteparin (Fragmin) (PDF) CP.PHAR.225 Retire by April 1, 2025
Dalteparin (Fragmin) (PDF)  CP.PHAR.225  April 1, 2025
Danicopan (ALXN2040) (PDF) CP.PHAR.665 January 1, 2025
Daprodustat (Jesduvroq) (PDF) CP.PHAR.628 August 1, 2024
Dapsone (Aczone Gel) (PDF) CP.PCH.32 January 1, 2025
Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (PDF) CP.PHAR.351 September 1, 2024
Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF) CP.PHAR.310 November 1, 2024
Darbepoetin alfa (Aranesp) (PDF) CP.PHAR.236 January 1, 2025
Darolutamide (Nubeqa) (PDF) CP.PHAR.435 January 1, 2025
Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF) HIM.PA.SP61 January 1, 2025
Dasatinib (Sprycel) (PDF) CP.PHAR.72 January 1, 2025
Daunorubicin/Cytarabine (Vyxeos) (PDF) CP.PHAR.352 January1, 2025
DaxibotulinumtoxinA-lanm (Daxxify) (PDF) CP.PHAR.651 January 1, 2025
Decitabine-Cedazuridine (Inqovi) (PDF) CP.PHAR.479 January 1, 2025
Deferasirox (Exjade Jadenu) (PDF) CP.PHAR.145 January 1, 2025
Deferiprone (Ferriprox) (PDF) CP.PHAR.147 January 1, 2025
Deferoxamine (Desferal) (PDF) CP.PHAR.146 September 1, 2024
Deflazacort (Emflaza) (PDF) CP.PHAR.331 Retire by April 1, 2025
Deflazacort (Emflaza) (PDF)  CP.PHAR.331  April 1, 2025
Degarelix Acetate (Firmagon) (PDF) CP.PHAR.170 January 1, 2025
Delafloxacin (Baxdela) (PDF) CP.PMN.115 September 1, 2024
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF) CP.PHAR.593 Retire by June 1, 2025
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF)  CP.PHAR.593  June 1, 2025
Denileukin Diftitox-cxdl (Lymphir) (PDF) CP.PHAR.693 January 1, 2025
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF) CP.PHAR.58 Retire by June 1, 2025
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF)   CP.PHAR.58  June 1, 2025
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF) CP.PHAR.214 Retire by June 1, 2025
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF)  CP.PHAR.214  June 1, 2025
Deutetrabenazine (Austedo) (PDF) CP.PCH.42 January 1, 2025
Dexrazoxane (Totect) (PDF) CP.PHAR.418 July 1, 2024
Dextromethorphan-bupropion (Auvelity) (PDF) CP.PMN.284 January 1, 2025
Dextromethorphan-Quinidine (Nuedexta) (PDF) CP.PMN.93 April 1, 2025
Diazepam (Libervant, Valtoco) (PDF) CP.PMN.216 January 1, 2025
Dichlorphenamide (Keveyis) (PDF) CP.PMN.261 Retire by April 1, 2025
Dichlorphenamide (Keveyis) (PDF)  CP.PMN.261  April 1, 2025
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) CP.PCH.28 January 1, 2025
Dimethyl fumarate (Tecfidera), diroximel fumarate, monomethyl fumarate (PDF) CP.PHAR.249 January 1, 2025
Dipeptidyl Peptidase-4 Inhibitors (PDF) HIM.PA.58 Retire by April 1, 2025
Dipeptidyl Peptidase-4 Inhibitors (PDF)  HIM.PA.58  April 1, 2025
Dolasetron (Anzemet) (PDF) CP.PMN.141 January 1, 2025
Donanemab-azbt (Kisunla) (PDF) CP.PHAR.594 March 1, 2025
Dornase alfa (Pulmozyme) (PDF) CP.PHAR.212 January 1, 2025
Dostarlimab-gxly (Jemperli) (PDF) CP.PHAR.540 November 1, 2024
Doxepin (Silenor, Prudoxin, Zonalon) HIM.PA.147 January 1, 2025
Doxycycline (Doryx, Oracea, Acticlate) (PDF) CP.PMN.79 January 1, 2025
Dupilumab (Dupixent) (PDF) HIM.PA.SP69 Retire by June 1, 2025
Dupilumab (Dupixent) (PDF)  HIM.PA.SP69 June 1, 2025
Durvalumab (Imfinzi) (PDF) CP.PHAR.339 Retire by April 1, 2025
Durvalumab (Imfinzi) (PDF)  CP.PHAR.339  April 1, 2025
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF) CP.PMN.128 January 1, 2025
Duvelisib (Copiktra) (PDF) CP.PHAR.400 January 1, 2025
Ecallantide (Kalbitor) (PDF) CP.PHAR.177 September 1, 2024
Eculizumab (Soliris) (PDF) CP.PHAR.97 January 1, 2025
Edaravone (Radicava, Radicava ORS) (PDF) CP.PHAR.343 June 1, 2024
Efgartigimod Alfa-fcab, Efgartigimod/-Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF) CP.PHAR.555 Retire by June 1, 2025
Efgartigimod Alfa-fcab, Efgartigimod/-Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF)   CP.PHAR.555  June 1, 2025
Efinaconazole (Jublia) (PDF) CP.PMN.25 Retire by April 1, 2025
Efinaconazole (Jublia) (PDF)  CP.PMN.25  April 1, 2025
Eflornithine (Iwilfin) (PDF) CP.PHAR.670 Retire by April 1, 2025
Eflornithine (Iwilfin) (PDF)  CP.PHAR.670  April 1, 2025
Elacestrant (Orserdu) (PDF) CP.PHAR.623 January 1, 2025
Eladocagene Exuparvovec-tneq (Kebilidi) (PDF) CP.PHAR.595 April 1, 2025
Elafibranor (Iqirvo) (PDF) CP.PHAR.688 January 1, 2025
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF) CP.PHAR.136 January 1, 2025
Elapegademase-lvlr (Revcovi) (PDF) CP.PHAR.419 June 1, 2024
Elbasvir/Grazoprevir (Zepatier) (PDF) HIM.PA.SP62 January 1, 2025
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF) CP.PHAR.440 Retire by April 1, 2025
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF)  CP.PHAR.440  April 1, 2025
Eliglustat (Cerdelga) (PDF) CP.PHAR.153 January 1, 2025
Elivaldogene Autotemcel (Skysona) (PDF) CP.PHAR.556 January 1, 2025
Elosulfase Alfa (Vimizim) (PDF) CP.PHAR.162 June 1, 2024
Elotuzumab (Empliciti) (PDF) CP.PHAR.308 March 1, 2025
Elranatamab-bcmm (Elrexfio) (PDF) CP.PHAR.652 January 1, 2025
Eltrombopag (Promacta®) (PDF) CP.PHAR.180 Retire by April 1, 2025
Eltrombopag (Promacta®) (PDF)  CP.PHAR.180  April 1, 2025
Eluxadoline (Viberzi) (PDF) CP.PMN.170 January 1, 2025
Emapalumab-lzsg (Gamifant) (PDF) CP.PHAR.402 Retire by April 1, 2025
Emapalumab-lzsg (Gamifant) (PDF)  CP.PHAR.402  April 1, 2025
Emicizumab-kxwh (Hemlibra) (PDF) CP.PHAR.370 Retire by April 1, 2025
Emicizumab-kxwh (Hemlibra) (PDF)  CP.PHAR.370  April 1, 2025
Emtricitabine-tenofovir alafenamide (Descovy) (PDF) CP.PMN.235 Retire by April 1, 2025
Emtricitabine-tenofovir alafenamide (Descovy) (PDF)  CP.PMN.235  April 1, 2025
Ensartinib (Ensacove) (PDF) CP.PHAR.712 April 1, 2025
Enasidenib (Idhifa) (PDF) CP.PHAR.363 January 1, 2025
Encorafenib (Braftovi) (PDF) CP.PHAR.127 Retire by April 1, 2025
Encorafenib (Braftovi) (PDF)  CP.PHAR.127  April 1, 2025
Enfortumab Vedotin-ejfv (Padcev) (PDF) CP.PHAR.455 Retire by April 1, 2025
Enfortumab Vedotin-ejfv (Padcev) (PDF)  CP.PHAR.455  April 1, 2025
Enfuvirtide (Fuzeon) (PDF) CP.PHAR.41 August 1, 2024
Enoxaparin (Lovenox) (PDF) CP.PHAR.224 Retire by April 1, 2025
Enoxaparin (Lovenox) (PDF)  CP.PHAR.224  April 1, 2025
Entecavir (Baraclude) (PDF) HIM.PA.08 January 1, 2025
Entrectinib (Rozlytrek) (PDF) CP.PHAR.441 January 1, 2025
Enzalutamide (Xtandi) (PDF) CP.PHAR.106 Retire by April 1, 2025
Enzalutamide (Xtandi) (PDF)  CP.PHAR.106 April 1, 2025
Epcoritamab-bysp (Epkinly) (PDF) CP.PHAR.634 September 1, 2024
Eplontersen (Wainua) CP.PHAR.633 January 1, 2025
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF) CP.PHAR.237 August 1, 2024
Epoprostenol (Flolan, Veletri) (PDF) CP.PHAR.192 Retire by April 1, 2025
Epoprostenol (Flolan, Veletri) (PDF)  CP.PHAR.192  April 1, 2025
Eptinezumab-jjmr (Vyepti) (PDF) HIM.PA.SP64 March 1, 2025
Erdafitinib (Balversa) (PDF) CP.PHAR.423 January 1, 2025
Erenumab-aaoe (Aimovig) (PDF) HIM.PA.SP65 January 1, 2025
Eribulin Mesylate (Halaven) (PDF) CP.PHAR.318 January 1, 2025
Erlotinib (Tarceva) (PDF) CP.PHAR.74 January 1, 2025
Erwinia Asparaginase (Erwinaze, Rylaze) (PDF) CP.PHAR.301 Retire by April 1, 2025
Erwinia Asparaginase (Erwinaze, Rylaze) (PDF)  CP.PHAR.301  April 1, 2025
Esketamine (Spravato) (PDF) CP.PMN.199 May 1, 2024
Estradiol Vaginal Ring (Femring) (PDF) CP.PMN.263 January 1, 2025
Etelcalcetide (Parsabiv) (PDF) CP.PHAR.379 September 1, 2024
Eteplirsen (Exondys 51) (PDF) CP.PHAR.288 Retire by April 1, 2025
Eteplirsen (Exondys 51) (PDF)  CP.PHAR.288  April 1, 2025
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF) CP.PHAR.580 Retire by April 1, 2025
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF)  CP.PHAR.580  April 1, 2025
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF) CP.PHAR.63 Retire by April 1, 2025
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF)  CP.PHAR.63  April 1, 2025
Evinacumab-dgnb (Evkeeza) (PDF) HIM.PA.166 Retire by April 1, 2025
Evinacumab-dgnb (Evkeeza) (PDF)  HIM.PA.166  April 1, 2025
Evolocumab (Repatha) (PDF) HIM.PA.156 Retire by April 1, 2025
Evolocumab (Repatha) (PDF)  HIM.PA.156  April 1, 2025
Exagamglogene autotemcel (Casgevy) (PDF) CP.PHAR.603 Retire by June 1, 2025
Exagamglogene autotemcel (Casgevy) (PDF)  CP.PHAR.603  June 1, 2025
Factor IX (Human, Recombinant) (PDF) CP.PHAR.218 Retire by April 1, 2025
Factor IX (Human, Recombinant) (PDF)  CP.PHAR.218  April 1, 2025
Factor IX Complex, Human (Profilnine) (PDF) CP.PHAR.219 Retire by April 1, 2025
Factor IX Complex, Human (Profilnine) (PDF)  CP.PHAR.219  April 1, 2025
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF) CP.PHAR.220 Retire by June 1, 2025
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF)   CP.PHAR.220  June 1, 2025
Factor VIII (Human, Recombinant) (PDF) CP.PHAR.215 Retire by April 1, 2025
Factor VIII (Human, Recombinant) (PDF)  CP.PHAR.215  April 1, 2025
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF) CP.PHAR.216 Retire by June 1, 2025
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF)   CP.PHAR.216  June 1, 2025
Factor XIII A-Subunit, Recombinant (Tretten) (PDF) CP.PHAR.222 Retire by April 1, 2025
Factor XIII A-Subunit, Recombinant (Tretten) (PDF)  CP.PHAR.222  April 1, 2025
Factor XIII, Human (Corifact) (PDF) CP.PHAR.221 Retire by April 1, 2025
Factor XIII, Human (Corifact) (PDF)  CP.PHAR.221  April 1, 2025
Famotidine-Ibuprofen (Duexis) (PDF) CP.PMN.120 January 1, 2025
Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF) CP.PHAR.456 Retire by April 1, 2025
Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF)  CP.PHAR.456  April 1, 2025
Faricimab-svoa (Vabysmo) (PDF) CP.PHAR.581 Retire by April 1, 2025
Faricimab-svoa (Vabysmo) (PDF)  CP.PHAR.581  April 1, 2025
Febuxostat (Uloric) (PDF) CP.PMN.57 Retire by April 1, 2025
Febuxostat (Uloric) (PDF)  CP.PMN.57  April 1, 2025
Fecal microbiota spores, live-brpk (Vowst) (PDF) CP.PHAR.632 January 1, 2025
Fecal microbiota, live-jslm (Rebyota) (PDF) CP.PHAR.613 Retire by April 1, 2025
Fecal microbiota, live-jslm (Rebyota) (PDF)  CP.PHAR.613  April 1, 2025
Fedratinib (Inrebic) (PDF) CP.PHAR.442 January 1, 2025
Fenfluramine (Fintepla) (PDF) CP.PMN.246 January 1, 2025
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF) CP.PMN.127 January 1, 2025
Ferric Carboxymaltose (Injectafer) (PDF) CP.PHAR.234 Retire by April 1, 2025
Ferric Carboxymaltose (Injectafer) (PDF)  CP.PHAR.234  April 1, 2025
Ferric Derisomaltose (Monoferric) (PDF)  CP.PHAR.480 November 1, 2024
Ferric Maltol (Accrufer) (PDF) CP.PMN.213 January 1, 2025
Ferric Pyrophosphate (Triferic, Triferic Avnu ) (PDF) CP.PHAR.624 June 1, 2024
Ferumoxytol (Feraheme) (PDF) CP.PHAR.165 Retire by April 1, 2025
Ferumoxytol (Feraheme) (PDF)  CP.PHAR.165  April 1, 2025
Fezolinetant (Veozah) (PDF) CP.PMN.289 March 1, 2025
Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF) CP.PHAR.526 November 1, 2024
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) CP.PHAR.643 January1, 2025
Filgrastim (Neupogen, Zarxio, Granix, Nivestym, Releuko, Nypozi) (PDF) CP.PHAR.297 January 1, 2025
Finerenone (Kerendia) (PDF) CP.PMN.266 January 1, 2025
Fingolimod (Gilenya) (PDF) CP.PCH.38 January 1, 2025
Flibanserin (Addyi) (PDF) CP.PHAR.446 January 1, 2025
Fluorouracil Cream (Tolak) (PDF) CP.PMN.165 January 1, 2025
Fluticasone Propionate (Xhance) (PDF) CP.PMN.95 January 1, 2025
Fondaparinux (Arixtra) (PDF) CP.PHAR.226 Retire by April 1, 2025
Fondaparinux (Arixtra) (PDF) CP.PHAR.226 April 1, 2025
Fosdenopterin (Nulibry) (PDF) CP.PHAR.471 June 1, 2024
Fostamatinib (Tavalisse) (PDF) CP.PHAR.24 Retire by April 1, 2025
Fostamatinib (Tavalisse) (PDF)  CP.PHAR.24  April 1, 2025
Fostemsavir (Rukobia) (PDF) CP.PHAR.516 Retire by April 1, 2025
Fostemsavir (Rukobia) (PDF)  CP.PHAR.516  April 1, 2025
Fremanezumab-vfrm (Ajovy)(PDF) HIM.PA.SP66 January 1, 2025
Fruquintinib (Fruzaqla) (PDF) CP.PHAR.666 Retire by April 1, 2025
Fruquintinib (Fruzaqla) (PDF)  CP.PHAR.666  April 1, 2025
Fulvestrant (Faslodex Injection) (PDF)  CP.PHAR.424 October 1, 2024
Furosemide (Furoscix) (PDF) CP.PHAR.608 Retire by April 1, 2025
Furosemide (Furoscix) (PDF)  CP.PHAR.608  April 1, 2025
Futibatinib (Lytgobi) (PDF) CP.PHAR.604 Retire by April 1, 2025
Futibatinib (Lytgobi) (PDF)  CP.PHAR.604  April 1, 2025
Gabapentin ER (Gralise, Horizant) (PDF) CP.PMN.240 January 1, 2025
Galcanezumab-gnlm (Emgality) (PDF) HIM.PA.SP67 January 1, 2025
Galsulfase (Naglazyme) (PDF) CP.PHAR.161 June 1, 2024
Ganaxolone (Ztalmy) (PDF) CP.PMN.278 January 1, 2025
Gefitinib (Iressa) (PDF) CP.PHAR.68 January 1, 2025
Gemtuzumab Ozogamicin (Mylotarg) (PDF) CP.PHAR.358 January1, 2025
Gilteritinib (Xospata) (PDF) CP.PHAR.412 Retire by April 1, 2025
Gilteritinib (Xospata) (PDF)  CP.PHAR.412  April 1, 2025
Givinostat (Duvyzat) (PDF) CP.PHAR.644 January 1, 2025
Givosiran (Givlaari) (PDF) CP.PHAR.457 Retire by April 1, 2025
Givosiran (Givlaari) (PDF)  CP.PHAR.457  April 1, 2025
Glasdegib (Daurismo)(PDF) CP.PHAR.413 Retire by April 1, 2025
Glasdegib (Daurismo)(PDF)  CP.PHAR.413  April 1, 2025
Glatiramer (Copaxone, Glatopa) (PDF) CP.PHAR.252 January 1, 2025
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF) CP.PMN.286 Retire by April 1, 2025
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF)  CP.PMN.286  April 1, 2025
Glecaprevir/Pibrentasvir (Mavyret)(PDF) HIM.PA.SP36 January 1, 2025
Glofitamab-gxbm (Columvi) (PDF) CP.PHAR.636 September 1, 2024
GLP-1 Receptor Agonists (PDF) AR.QC.PA.53 January 1, 2025
Glycerol Phenylbutyrate (Ravicti) (PDF) CP.PHAR.207 Retire by April 1, 2025
Glycerol Phenylbutyrate (Ravicti) (PDF)  CP.PHAR.207  April 1, 2025
Golodirsen (Vyondys 53) (PDF) CP.PHAR.453 Retire by April 1, 2025
Golodirsen (Vyondys 53) (PDF)  CP.PHAR.453  April 1, 2025
Goserelin Acetate (Zoladex) (PDF) CP.PHAR.171 January 1, 2025
Granisetron (Sancuso, Sustol) (PDF) CP.PMN.74 January 1, 2025
Halcinonide (Halog) (PDF) HIM.PA.20 January 1, 2025
Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF) CP.PMN.180 January 1, 2025
Halobetasol Propionate/Tazarotene (Duobrii) (PDF) CP.PMN.208 January 1, 2025
Hemin (Panhematin) (PDF) CP.PHAR.181 Retire by April 1, 2025
Hemin (Panhematin) (PDF)  CP.PHAR.181  April 1, 2025
Histrelin Acetate (Vantas, Supprelin LA) (PDF) CP.PHAR.172 July 1, 2024
House dust mite allergen extract (Odactra®) (PDF) CP.PMN.111 January 1, 2025
Human Growth Hormone (Somapacitan, Somatropin) (PDF) HIM.PA.161 Retire by April 1, 2025
Human Growth Hormone (Somapacitan, Somatropin) (PDF)  HIM.PA.161  April 1, 2025
Hyaluronate derivatives (PDF) CP.PHAR.05 January 1, 2025
Hydroxyprogesterone Caproate (Makena) (PDF) CP.PHAR.14 January 1, 2025
Hydroxyurea (Siklos, Xromi) (PDF) CP.PMN.193 Retire by April 1, 2025
Hydroxyurea (Siklos, Xromi) (PDF)  CP.PMN.193  April 1, 2025
Ibalizumab-uiyk (Trogarzo) (PDF) CP.PHAR.378 August 1, 2024
Ibandronate Injection (Boniva) (PDF) CP.PHAR.189 Retire by April 1, 2025
Ibandronate Injection (Boniva) (PDF)  CP.PHAR.189  April 1, 2025
Ibrutinib (Imbruvica) (PDF) CP.PHAR.126 Retire by June 1, 2025
Ibrutinib (Imbruvica) (PDF)  CP.PHAR.126  June 1, 2025
Icatibant (Firazyr®) (PDF) CP.PHAR.178 January 1, 2025
Icosapent ethyl (Vascepa) (PDF) CP.PMN.187 Retire by April 1, 2025
Icosapent ethyl (Vascepa) (PDF)  CP.PMN.187  April 1, 2025
Idecabtagene Vicleucel (Abecma) (PDF) CP.PHAR.481 January 1, 2025
Idelalisib (Zydelig) (PDF) CP.PHAR.133 January 1, 2025
Idursulfase (Elaprase) (PDF) CP.PHAR.156 June 1, 2024
Iloperidone (Fanapt) (PDF) CP.PMN.32 January 1, 2025
Iloprost (Ventavis®) (PDF) CP.PHAR.193 Retire by April 1, 2025
Iloprost (Ventavis®) (PDF)  CP.PHAR.193  April 1, 2025
Imatinib (Gleevec, Imkeldi) (PDF) CP.PHAR.65 January 1, 2025
Imetelstat (Rytelo) (PDF) CP.PHAR.690 January 1, 2025
Imiglucerase (Cerezyme) (PDF) CP.PHAR.154 June 1, 2024
Immune Globulins (PDF) CP.PHAR.103 January 1, 2025
Immune Globulins for PANS/PANDAS (PDF) AR.CP.PHAR.103 February 1, 2025
Inavolisib (Itovebi) (PDF) CP.PHAR.702 January 1, 2025
Inclisiran (Leqvio) (PDF) CP.PHAR.568 Retire by April 1, 2025
Inclisiran (Leqvio) (PDF)  CP.PHAR.568  April 1, 2025
IncobotulinumtoxinA (Xeomin) (PDF) CP.PHAR.231 October 1, 2024
Inebilizumab-cdon (Uplizna) (PDF) CP.PHAR.458 January 1, 2025
Inebilizumab-cdon (Uplizna) (PDF)  CP.PHAR.458 October 1, 2024
Infertility and Fertility Preservation (PDF) CP.PHAR.131 January 1, 2025
Inhaled Agents for Asthma and COPD (PDF) HIM.PA.153 Retire by April 1, 2025
Inhaled Agents for Asthma and COPD (PDF)  HIM.PA.153  April 1, 2025
Inotersen (Tegsedi) (PDF) CP.PHAR.405 January 1, 2025
Inotuzumab Ozogamicin (Besponsa) (PDF) CP.PHAR.359 January1, 2025
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)  CP.PHAR.534 Retire by April 1, 2025
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)    CP.PHAR.534  April 1, 2025
Insulin Detemir (Levemir) (PDF) HIM.PA.171 January 1, 2025
Insulin Glargine (Basaglar, Rezvoglar, Toujeo, unbranded Semglee) (PDF) HIM.PA.09 Retire by April 1, 2025
Insulin Glargine (Basaglar, Rezvoglar, Toujeo, unbranded Semglee) (PDF)   HIM.PA.09  April 1, 2025
Interferon Beta-1a (Avonex, Rebif) (PDF) CP.PHAR.255 January 1, 2025
Interferon beta-1b (Betaseron, Extavia) (PDF) CP.PCH.46 January 1, 2025
Interferon Gamma- 1b (Actimmune) (PDF) CP.PHAR.52 Retire by April 1, 2025
Interferon Gamma- 1b (Actimmune) (PDF)  CP.PHAR.52  April 1, 2025
Iobenguane I-131 (Azedra) (PDF) CP.PHAR.459 Retire by April 1, 2025
Iobenguane I-131 (Azedra) (PDF)  CP.PHAR.459  April 1, 2025
Ipilimumab (Yervoy) (PDF) CP.PHAR.319 June 1, 2024
Iptacopan (Fabhalta) (PDF) CP.PHAR.656 January 1, 2025
Irinotecan Liposome (Onivyde) (PDF) CP.PHAR.304 January1, 2025
Isatuximab-irfc (Sarclisa) (PDF) CP.PHAR.482 January 1, 2025
Isavuconazonium (Cresemba) (PDF) CP.PMN.154 June 1, 2024
Isotretinoin (Claravis Absorica Absorica LD Myorisan Zenatane Amnesteem) (PDF) CP.PMN.143 March 1, 2025
Istradefylline (Nourianz) (PDF) CP.PMN.217 Retire by April 1, 2025
Istradefylline (Nourianz) (PDF)  CP.PMN.217  April 1, 2025
Itraconazole (Sporanox, Onmel) (PDF) CP.PMN.124 January 1, 2025
Ivabradine (Corlanor) (PDF) CP.PMN.70 Retire by June 1, 2025
Ivabradine (Corlanor) (PDF)  CP.PMN.70  June 1, 2025
Ivacaftor (Kalydeco) (PDF) CP.PHAR.210 Retire by April 1, 2025
Ivacaftor (Kalydeco) (PDF)  CP.PHAR.210  April 1, 2025
Ivermectin (Stromectol, Sklice) (PDF) CP.PMN.269 January 1, 2025
Ivosidenib (Tibsovo) (PDF) CP.PHAR.137 January 1, 2025
Ixazomib (Ninlaro) (PDF) CP.PHAR.302 January 1, 2025
Ketamine (Ketalar) (PDF) CP.PMN.296 September 1, 2024
Ketorolac nasal spray (Sprix) (PDF) CP.PMN.282 January 1, 2025
Lanadelumab-fylo (Takhzyro) (PDF) HIM.PA.172 May 1, 2024
Lanreotide (Somatuline Depot and Unbranded) (PDF) CP.PHAR.391 January1, 2025
Lapatinib (Tykerb®) (PDF) CP.PHAR.79 January 1, 2025
Laronidase (Aldurazyme) (PDF) CP.PHAR.152 June 1, 2024
Larotrectinib (Vitrakvi)(PDF) CP.PHAR.414 Retire by April 1, 2025
Larotrectinib (Vitrakvi)(PDF)  CP.PHAR.414  April 1, 2025
Lasmiditan (Reyvow) (PDF) CP.PMN.218 Retire by June 1, 2025
Lasmiditan (Reyvow) (PDF)  CP.PMN.218  June 1, 2025
Lazertinib (Lazcluze) (PDF) CP.PHAR.695 January 1, 2025
Lebrikizumab (Ebglyss) (PDF)  CP.PHAR.704 January 1, 2025
Lecanemab-irmb (Leqembi) (PDF) CP.PHAR.596 March 1, 2025
Ledipasvir-Sofosbuvir (Harvoni) (PDF) HIM.PA.SP3 January 1, 2025
Lefamulin (Xenleta) (PDF) CP.PMN.219 September 1, 2024
Lenacapavir (Sunlenca) (PDF) CP.PHAR.622 May 1, 2024
Lenalidomide (Revlimid) (PDF) CP.PHAR.71 January 1, 2025
Leniolisib (Joenja) (PDF) CP.PHAR.597 January 1, 2025
Lenvatinib (Lenvima) (PDF) CP.PHAR.138 January 1, 2025
Letermovir (Prevymis) (PDF) CP.PHAR.367 Retire by April 1, 2025
Letermovir (Prevymis) (PDF)  CP.PHAR.367  April 1, 2025
Leucovorin Injection (PDF) CP.PHAR.393 May 1, 2024
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) CP.PHAR.173 May 1, 2024
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF) CP.PCH.53 January 1, 2025
Levodopa Inhalation Powder (Inbrija) (PDF) CP.PMN.267 January 1, 2025
Levoketoconazole (Recorlev) (PDF) CP.PMN.275 January 1, 2025
Levoleucovorin (Fusilev, Khapzory) (PDF) CP.PHAR.151 January 1, 2025
Levomilnacipran (Fetzima) (PDF) HIM.PA.125 January 1, 2025
L-glutamine (Endari) (PDF) CP.PMN.116 January 1, 2025
Lidocaine Transdermal (Lidoderm, ZTlido) (PDF) CP.PMN.08 January 1, 2025
Lifileucel (Amtagvi) (PDF) CP.PHAR.598 January 1, 2025
Lifitegrast (Xiidra®) (PDF) CP.PMN.73 Retire by April 1, 2025
Lifitegrast (Xiidra®) (PDF)  CP.PMN.73  April 1, 2025
Linezolid (Zyvox) (PDF) CP.PMN.27 August 1, 2024
Lisocabtagene Maraleucel (Breyanzi) (PDF) CP.PHAR.483 August 1, 2024
Lofexidine (Lucemyra) (PDF) CP.PMN.152 January 1, 2025
Lomustine (Gleostine) (PDF) CP.PHAR.507 January 1, 2025
Lonafarnib (Zokinvy) (PDF) CP.PHAR.499 Retire by April 1, 2025
Lonafarnib (Zokinvy) (PDF)  CP.PHAR.499  April 1, 2025
Loncastuximab Tesirine-lpyl (Zynlonta) (PDF) CP.PHAR.539 September 1, 2024
Lorlatinib (Lorbrena)(PDF) CP.PHAR.406 January 1, 2025
Loteprednol etabonate (Eysuvis) (PDF) CP.PMN.260 Retire by April 1, 2025
Loteprednol etabonate (Eysuvis) (PDF)  CP.PMN.260  April 1, 2025
Lotilaner (Xdemvy) (PDF) CP.PMN.291 January 1, 2025
Lovotibeglogene Autotemcel (Lyfgenia) (PDF) CP.PHAR.627 Retire by June 1, 2025
Lovotibeglogene Autotemcel (Lyfgenia) (PDF)  CP.PHAR.627  June 1, 2025
Lubiprostone (Amitiza) (PDF) CP.PMN.142 January 1, 2025
Luliconazole Cream (Luzu) (PDF) CP.PMN.166 Retire by April 1, 2025
Luliconazole Cream (Luzu) (PDF)  CP.PMN.166  April 1, 2025
Lumacaftor-Ivacaftor (Orkambi) (PDF) CP.PHAR.213 Retire by April 1, 2025
Lumacaftor-Ivacaftor (Orkambi) (PDF)  CP.PHAR.213  April 1, 2025
Lumasiran (Oxlumo) (PDF) CP.PHAR.473 Retire by April 1, 2025
Lumasiran (Oxlumo) (PDF)  CP.PHAR.473  April 1, 2025
Lumateperone (Caplyta) (PDF) CP.PMN.232 January 1, 2025
Lurbinectedin (Zepzelca) (PDF) CP.PHAR.500 September 1, 2024
Luspatercept-aamt (Reblozyl) (PDF) CP.PHAR.450 Retire by April 1, 2025
Luspatercept-aamt (Reblozyl) (PDF)  CP.PHAR.450  April 1, 2025
Lusutrombopag (Mulpleta)(PDF) CP.PHAR.407 Retire by April 1, 2025
Lusutrombopag (Mulpleta)(PDF)  CP.PHAR.407  April 1, 2025
Lutetium Lu 177 dotatate (Lutathera) (PDF) CP.PHAR.384 September 1, 2024
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF) CP.PHAR.582 June 1, 2024
Macitentan (Opsumit) (PDF) CP.PHAR.194 Retire by April 1, 2025
Macitentan (Opsumit) (PDF)  CP.PHAR.194  April 1, 2025
Mannitol (Bronchitol) (PDF) CP.PHAR.518 January 1, 2025
Maralixibat (Livmarli) (PDF) CP.PHAR.543 January 1, 2025
Margetuximab-cmkb (Margenza) (PDF) CP.PHAR.522 Retire by April 1, 2025
Margetuximab-cmkb (Margenza) (PDF)  CP.PHAR.522  April 1, 2025
Maribavir (Livtencity) (PDF) CP.PMN.271 Retire by April 1, 2025
Maribavir (Livtencity) (PDF)  CP.PMN.271  April 1, 2025
Marstacimab-hncq (Hympavzi) (PDF) CP.PHAR.674 April 1, 2025
Mavacamten (Camzyos) (PDF) CP.PMN.272 January 1, 2025
Mavorixafor (Xolremdi) CP.PHAR.679 January 1, 2025
Mecamylamine (Vecamyl) (PDF) CP.PMN.136 January 1, 2025
Mecasermin (Increlex) (PDF) CP.PHAR.150 October 1, 2024
Megestrol Acetate (PDF) CP.PMN.179 January 1, 2025
Melphalan (Hepzato) (PDF) CP.PHAR.653 January 1, 2025
Melphalan flufenamide (Pepaxto) (PDF) CP.PHAR.535 June 1, 2024
Memantine (Namenda XR, Namzaric) (PDF) CP.PCH.30 January 1, 2025
Mepolizumab (Nucala) (PDF) CP.PHAR.200 January 1, 2025
Mercaptopurine (Purixan) (PDF) CP.PHAR.447 January 1, 2025
Metformin ER (Glumetza, Fortamet) (PDF) CP.PMN.72 Retire by April 1, 2025
Metformin ER (Glumetza, Fortamet) (PDF)  CP.PMN.72  April 1, 2025
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF) CP.PHAR.134 January 1, 2025
Methoxsalen (Uvadex) (PDF) HIM.PA.17 January 1, 2025
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF) CP.PHAR.238 January 1, 2025
Methylnaltrexone Bromide (Relistor) (PDF) CP.PMN.169 January 1, 2025
Metoclopramide (Gimoti) (PDF) CP.PMN.252 January 1, 2025
Metreleptin (Myalept) (PDF) CP.PHAR.425 September 1, 2024
Midazolam (Nayzilam) (PDF) CP.PMN.211 January 1, 2025
Midostaurin (Rydapt) (PDF) CP.PHAR.344 January 1, 2025
Mifepristone (Korlym) (PDF) CP.PHAR.101 Retire by June 1, 2025
Mifepristone (Korlym) (PDF)  CP.PHAR.101  June 1, 2025
Migalastat (Galafold) (PDF) CP.PHAR.394 January 1, 2025
Miglustat (Zavesca) (PDF) CP.PHAR.164 Retire by April 1, 2025
Miglustat (Zavesca) (PDF)  CP.PHAR.164  April 1, 2025
Milnacipran (Savella) (PDF) CP.PMN.125 January 1, 2025
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF) CP.PMN.80 January 1, 2025
Mirvetuximab soravatansine-gynx (Elahere) (PDF)  CP.PHAR.617 Retire by April 1, 2025
Mirvetuximab soravatansine-gynx (Elahere) (PDF)   CP.PHAR.617  April 1, 2025
Mitapivat (Pyrukynd) (PDF) CP.PHAR.558 January 1, 2025
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) CP.PHAR.495 September 1, 2024
Mitoxantrone (PDF) CP.PHAR.258 July 1, 2024
Mixed pollens allergen extract (Oralair) (PDF) CP.PMN.85 January 1, 2025
Mobocertinib (Exkivity) (PDF) CP.PHAR.559 January 1, 2025
Modafinil (Provigil) (PDF) CP.PMN.39 January 1, 2025
Mogamulizumab-kpkc (Poteligeo) (PDF) CP.PHAR.139 March 1, 2025
Momelotinib (Ojjaara) (PDF) CP.PHAR.654 January 1, 2025
Mometasone (Nasonex) (PDF) HIM.PA.93 January 1, 2025
Mometasone Furoate (Sinuva) (PDF) CP.PHAR.448 August 1, 2024
Mosunetuzumab-axgb (Lunsumio) (PDF) CP.PHAR.618 Retire by April 1, 2025
Mosunetuzumab-axgb (Lunsumio) (PDF)  CP.PHAR.618  April 1, 2025
Motixafortide (Aphexda) (PDF) CP.PHAR.655 January 1, 2025
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) CP.PHAR.398 January 1, 2025
Nabumatone Double-Strength (Relafen DS) (PDF) CP.PMN.287 January 1, 2025
Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF) CP.PHAR.461 March 1, 2025
Nafarelin acetate (Synarel®) (PDF) CP.PHAR.174 January 1, 2025
Naldemedine (Symproic) (PDF) CP.PMN.112 January 1, 2025
Nalmefene (Opvee, Zurnai) (PDF) CP.PHAR.638 January 1, 2025
Naloxegol (Movantik) (PDF) HIM.PA.167 January 1, 2025
Naproxen oral suspension (Naprosyn) (PDF) HIM.PA.130 January 1, 2025
Natalizumab (Tysabri) (PDF) CP.PHAR.259 September 1, 2024
Naxitamab-gqgk (Danyelza) (PDF) CP.PHAR.523 Retire by April 1, 2025
Naxitamab-gqgk (Danyelza) (PDF)  CP.PHAR.523  April 1, 2025
Necitumumab (Portrazza) (PDF) CP.PHAR.320 January 1, 2025
Nedosiran (Rivfloza) (PDF) CP.PHAR.619 Retire by April 1, 2025
Nedosiran (Rivfloza) (PDF)  CP.PHAR.619  April 1, 2025
Nemolizumab-ito (Nemluvio) (PDF) CP.PHAR.703 Retire by June 1, 2025
Nemolizumab-ito (Nemluvio) (PDF)  CP.PHAR.703  June 1, 2025
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) CP.PMN.167 January 1, 2025
Neratinib (Nerlynx) (PDF) CP.PHAR.365 January 1, 2025
Netupitant and Palonosetron (Akynzeo) (PDF) CP.PMN.158 January 1, 2025
Nifurtimox (Lampit)  (PDF) CP.PMN.256 January 1, 2025
Nilotinib (Tasigna, Danziten) (PDF) CP.PHAR.76 March 1, 2025
Nintedanib (Ofev) (PDF) CP.PHAR.285 January 1, 2025
Niraparib (Zejula) (PDF) CP.PHAR.408 Retire by April 1, 2025
Niraparib (Zejula) (PDF)  CP.PHAR.408  April 1, 2025
Niraparib and Abiraterone (Akeega) (PDF) CP.PHAR.645 January 1, 2025
Nirmatrelvir-Ritonavir (Paxlovid) (PDF) CP.PMN.288 January 1, 2025
Nirogacestat (Ogsiveo) (PDF) CP.PHAR.671 Retire by April 1, 2025
Nirogacestat (Ogsiveo) (PDF)  CP.PHAR.671  April 1, 2025
Nirsevimab-alip (Beyfortus) (PDF) CP.PHAR.614 September 1, 2024
Nitazoxanide (Alinia) (PDF) HIM.PA.152 January 1, 2025
Nitisinone (Nityr, Orfadin) (PDF) CP.PHAR.132 January 1, 2025
Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) Nivolumab (Opdivo) (PDF) CP.PHAR.121 June 1, 2025
Nivolumab and Relatlimab-rmbw (Opdualag) (PDF) CP.PHAR.588 September 1, 2024
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) HIM.PA.33 January 1, 2025
Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF) CP.PHAR.684 January 1, 2025
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF) CP.PMN.04 Retire by June 1, 2025
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF)   CP.PMN.04  June 1, 2024
Non-Formulary and Formulary Contraceptives (PDF) HIM.PA.100 January 1, 2025
Non-Formulary Test Strips (PDF) HIM.PA.34 Retire by April 1, 2025
Non-Formulary Test Strips (PDF)  HIM.PA.34  April 1, 2025
Nusinersen (Spinraza) (PDF) CP.PHAR.327 Retire by April 1, 2025
Nusinersen (Spinraza) (PDF)  CP.PHAR.327  April 1, 2025
Obecabtagene autoleucel (Aucatzyl) (PDF) CP.PHAR.675 April 1, 2025
Obeticholic acid (Ocaliva) (PDF) CP.PHAR.287 January 1, 2025
Obinutuzumab (Gazyva) (PDF) CP.PHAR.305 January 1, 2025
Ocrelizumab (Ocrevus) (PDF) CP.PHAR.335 January 1, 2025
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF) CP.PHAR.40 Retire by June 1, 2025
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)   CP.PHAR.40  June 1, 2025
Odevixibat (Bylvay) (PDF) CP.PHAR.528 January 1, 2025
Ofatumumab (Arzerra, Kesimpta) (PDF) CP.PHAR.306 June 1, 2024
Off-Label Drug Use (PDF) HIM.PA.154 January 1, 2025
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF) CP.PHAR.292 May 1, 2024
Olanzapine-samidorphan (Lybalvi) (PDF) CP.PMN.265 January 1, 2025
Olaparib (Lynparza) (PDF) CP.PHAR.360 Retire by April 1, 2025
Olaparib (Lynparza) (PDF)  CP.PHAR.360  April 1, 2025
Olipudase Alfa-rpcp (Xenpozyme) (PDF) CP.PHAR.586 September 1, 2024
Olutasidenib (Rezlidhia) (PDF) CP.PHAR.615 Retire by April 1, 2025
Olutasidenib (Rezlidhia) (PDF)  CP.PHAR.615  April 1, 2025
Omacetaxine (Synribo) (PDF) CP.PHAR.108 June 1, 2024
Omadacycline (Nuzyra) (PDF) CP.PMN.188 September 1, 2024
Omalizumab (Xolair) (PDF) CP.PCH.49 Retire by June 1, 2025
Omalizumab (Xolair) (PDF) CP.PCH.49 June 1, 2025
Omaveloxolone (RTA-408) (PDF) CP.PHAR.590 January 1, 2025
OnabotulinumtoxinA (Botox) (PDF) CP.PHAR.232 January 1, 2025
OnabotulinumtoxinA (Botox) (PDF)  CP.PHAR.232 January 1, 2025
Onasemnogene Abeparvovec (Zolgensma) (PDF) CP.PHAR.421 September 1, 2024
Ophthalmic Corticosteroids (PDF) HIM.PA.03 January 1, 2025
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF) CP.PHAR.536 January 1, 2025
Opicapone (Ongentys) (PDF) CP.PMN.245 January 1, 2025
Opioid Analgesics (PDF) HIM.PA.139 January 1, 2025
Osilodrostat (Isturisa) (PDF) CP.PHAR.487 January 1, 2025
Osimertinib (Tagrisso) (PDF) CP.PHAR.294 January 1, 2025
Ospemifene (Osphena) (PDF) CP.PMN.168 January 1, 2025
Overactive Bladder Agents (PDF) CP.PMN.198 Retire by April 1, 2025
Overactive Bladder Agents (PDF)  CP.PMN.198  April 1, 2025
Oxymetazoline (Rhofade) (PDF) CP.PMN.86 January 1, 2025
Ozanimod (Zeposia) (PDF) CP.PHAR.462 January 1, 2025
Ozenoxacin (Xepi) (PDF) CP.PMN.119 January 1, 2025
Paclitaxel, Protein-Bound (Abraxane) (PDF) CP.PHAR.176 January 1, 2025
Pacritinib (Vonjo) (PDF) CP.PHAR.583 January 1, 2025
Palbociclib (Ibrance) (PDF) HIM.PA.173 January 1, 2025
Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF) CP.PHAR.291 May 1, 2024
Palivizumab (Synagis) (PDF) CP.PHAR.16 May 1, 2024
Palopegteriparatide (Yorvipath) (PDF) CP.PHAR.696 January 1, 2025
Palovarotene (PDF) CP.PHAR.548 January 1, 2025
Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF) CP.PCH.44 March 1, 2025
Panitumumab (Vectibix) (PDF) CP.PHAR.321 March 1, 2025
Parathyroid Hormone (Natpara) (PDF) CP.PHAR.282 Retire by April 1, 2025
Parathyroid Hormone (Natpara) (PDF)  CP.PHAR.282  April 1, 2025
Paricalcitol Injection (Zemplar) (PDF) CP.PHAR.270 September 1, 2024
Pasireotide (Signifor, Signifor LAR) (PDF) CP.PHAR.332 January1, 2025
Patiromer (Veltassa) (PDF) CP.PMN.205 January 1, 2025
Patisiran (Onpattro) (PDF) CP.PHAR.395 July 1, 2024
Pazopanib (Votrient) (PDF) CP.PHAR.81 January 1, 2025
Peanut allergen powder (Palforzia) (PDF) CP.PMN.220 January 1, 2025
Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) CP.PHAR.353 March 1, 2025
Pegcetacoplan (Empaveli, APL-2) (PDF)  CP.PHAR.524 October 1, 2024
Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF) CP.PHAR.296 January 1, 2025
Peginterferon Alfa-2a (Pegasys) (PDF) CP.PHAR.89 January 1, 2025
Peginterferon beta-1a (Plegridy) (PDF) CP.PHAR.271 January 1, 2025
Pegloticase (Krystexxa) (PDF) CP.PHAR.115 Retire by April 1, 2025
Pegloticase (Krystexxa) (PDF)  CP.PHAR.115  April 1, 2025
Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF) CP.PHAR.512 September 1, 2024
Pegvaliase-pqpz (Palynziq) (PDF) CP.PHAR.140 March 1, 2025
Pegvisomant (Somavert) (PDF) CP.PHAR.389 January 1, 2025
Pembrolizumab (Keytruda®) (PDF) CP.PHAR.322 January 1, 2025
Pemetrexed (Alimta, Pemfexy) (PDF) CP.PHAR.368 Retire by June 1, 2025
Pemetrexed (Alimta, Pemfexy, Axtle) (PDF)  CP.PHAR.368 June 1, 2025
Pemigatinib (Pemazyre) (PDF) CP.PHAR.496 January 1, 2025
Penicillamine (Cuprimine) (PDF) CP.PCH.09 January 1, 2025
Perampanel (Fycompa) (PDF) CP.PMN.156 January 1, 2025
Perfluorohexyloctane (Miebo) (PDF) CP.PMN.290 January 1, 2025
Pertuzumab (Perjeta) (PDF) CP.PHAR.227 June 1, 2024
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF) CP.PHAR.501 September 1, 2024
Pexidartinib (Turalio)(PDF) CP.PHAR.436 January 1, 2025
Phendimetrazine (PDF) CP.PCH.47 January 1, 2025
Phentermine (Adipex-P, Lomaira) (PDF) CP.PCH.13 January 1, 2025
Pilocarpine (Vuity) (PDF) CP.PMN.270 January 1, 2025
Pimavanserin (Nuplazid) (PDF) CP.PMN.140 January 1, 2025
Pirfenidone (Esbriet) (PDF) CP.PHAR.286 Retire by April 1, 2025
Pirfenidone (Esbriet) (PDF)  CP.PHAR.286  April 1, 2025
Pirtobrutinib (Jaypirca) (PDF) CP.PHAR.620 January 1, 2025
Pitolisant (Wakix) (PDF) CP.PMN.221 January 1, 2025
Plasminogen, human-tvmh (Ryplazim) (PDF) CP.PHAR.513 January1, 2025
Plecanatide (Trulance) (PDF) CP.PMN.87 January 1, 2025
Plerixafor (Mozobil) (PDF)  CP.PHAR.323 October 1, 2024
Polatuzumab Vedotin-piiq (Polivy) (PDF) CP.PHAR.433 September 1, 2024
Pomalidomide (Pomalyst) (PDF) CP.PHAR.116 January 1, 2025
Ponatinib (Iclusig) (PDF) CP.PHAR.112 January 1, 2025
Ponesimod (Ponvory) (PDF) CP.PHAR.537 January 1, 2025
Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF) HIM.PA.143 Retire by April 1, 2025
Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF)  HIM.PA.143  April 1, 2025
Pozelimab-bbfg (Veopoz) (PDF) CP.PHAR.626 June 1, 2024
Pralatrexate (Folotyn) (PDF) CP.PHAR.313 March 1, 2025
Pramlintide (Symlin) (PDF) CP.PMN.129 Retire by April 1, 2025
Pramlintide (Symlin) (PDF)  CP.PMN.129  April 1, 2025
Prasterone (Intrarosa) (PDF) CP.PMN.99 Retire by April 1, 2025
Prasterone (Intrarosa) (PDF)  CP.PMN.99  April 1, 2025
Pregabalin (Lyrica) (PDF) CP.PMN.33 January 1, 2025
Pretomanid (PDF) CP.PMN.222 Retire by April 1, 2025
Pretomanid (PDF)  CP.PMN.222  April 1, 2025
Progesterone (Crinone, Endometrin, Milprosa) (PDF) CP.PMN.243 January 1, 2025
Propranolol (Hemangeol) (PDF) CP.PCH.51 January 1, 2025
Protein C Concentrate, Human (Ceprotin) (PDF) CP.PHAR.330 Retire by April 1, 2025
Protein C Concentrate, Human (Ceprotin) (PDF)  CP.PHAR.330  April 1, 2025
Prucalopride (Motegrity) (PDF) HIM.PA.159 Retire by June 1, 2025
Prucalopride (Motegrity) (PDF)  HIM.PA.159  June 1, 2025
Pyrimethamine (Daraprim®) (PDF) CP.PMN.44 January 1, 2025
Quantity Limit Override and Dose Optimization (PDF) CP.PMN.59 January 1, 2025
Quetiapine ER (Seroquel XR) (PDF) CP.PMN.64 Retire by April 1, 2025
Quetiapine ER (Seroquel XR) (PDF)  CP.PMN.64  April 1, 2025
Quinine Sulfate (Qualaquin) (PDF) CP.PMN.262 January 1, 2025
Quizartinib (Vanflyta) (PDF) CP.PHAR.646 January 1, 2025
Ramucirumab (Cyramza) (PDF) CP.PHAR.119 Retire by April 1, 2025
Ramucirumab (Cyramza) (PDF)  CP.PHAR.119  April 1, 2025
Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF) CP.PHAR.186 Retire by April 1, 2025
Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF)  CP.PHAR.186  April 1, 2025
Rasagiline (Azilect®) (PDF) HIM.PA.89 January 1, 2025
Ravulizumab-cwvz (Ultomiris) (PDF)  CP.PHAR.415 October 1, 2024
Regorafenib (Stivarga) (PDF) CP.PHAR.107 January 1, 2025
Relugolix (Orgovyx) (PDF) CP.PHAR.529 January 1, 2025
Remetirom (Rezdiffra) (PDF) CP.PHAR.647 January 1, 2025
Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (PDF) HIM.PA.168 May 1, 2024
Repotrectinib (Augtyro) (PDF) CP.PHAR.667 Retire by April 1, 2025
Repotrectinib (Augtyro) (PDF)  CP.PHAR.667  April 1, 2025
Reslizumab (Cinqair) (PDF) CP.PHAR.223 Retire by April 1, 2025
Reslizumab (Cinqair) (PDF)  CP.PHAR.223  April 1, 2025
Respiratory syncytial virus vaccine (Abrysvo) (PDF) CP.PHAR.658 January 1, 2025
Retifanlimab-dlwr (Zynyz) (PDF) CP.PHAR.629 July 1, 2024
Revumenib (Revuforj) (PDF) CP.PHAR.707 April 1, 2025
Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF) CP.PHAR.141 January 1, 2025
Ribociclib (Kisqali, Kisqali Femara) (PDF) CP.PHAR.334 March 1, 2025
Rifabutin (Mycobutin) (PDF) CP.PMN.223 Retire by April 1, 2025
Rifabutin (Mycobutin) (PDF)  CP.PMN.223  April 1, 2025
Rifamycin (Aemcolo) (PDF) CP.PMN.196 January 1, 2025
Rifaximin (Xifaxan®) (PDF) CP.PMN.47 January 1, 2025
Rilonacept (Arcalyst) (PDF) CP.PHAR.266 July 1, 2024
RimabotulinumtoxinB (Myobloc) (PDF) CP.PHAR.233 June 1, 2024
Rimegepant (Nurtec ODT) (PDF) CP.PHAR.490 January 1, 2025
Riociguat (Adempas®) (PDF) CP.PHAR.195 Retire by April 1, 2025
Riociguat (Adempas®) (PDF)  CP.PHAR.195  April 1, 2025
Ripretinib (Qinlock) (PDF) CP.PHAR.502 January 1, 2025
Risdiplam (Evrysdi) (PDF) CP.PHAR.477 Retire by April 1, 2025
Risdiplam (Evrysdi) (PDF)  CP.PHAR.477  April 1, 2025
Risedronate (Actonel, Atelvia) (PDF) CP.PMN.100 Retire by June 1, 2025
Risedronate (Actonel, Atelvia) (PDF)  CP.PMN.100  June 1, 2025
Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (PDF) CP.PHAR.293 May 1, 2024
Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF) CP.PHAR.260 August 1, 2024
Roflumilast (Daliresp, Zoryve) (PDF) CP.PMN.46 January 1, 2025
Rolapitant (Varubi) (PDF) CP.PMN.102 January 1, 2025
Romidepsin (Istodax) (PDF) CP.PHAR.314 January1, 2025
Romiplostim (Nplate) (PDF) CP.PHAR.179 Retire by April 1, 2025
Romiplostim (Nplate) (PDF)  CP.PHAR.179  April 1, 2025
Romosozumab-aqqg (Evenity) (PDF) CP.PHAR.428 Retire by April 1, 2025
Romosozumab-aqqg (Evenity) (PDF)  CP.PHAR.428  April 1, 2025
Ropeginterferon Alfa-2b-njft (BESREMi) (PDF) CP.PHAR.570 Retire by April 1, 2025
Ropeginterferon Alfa-2b-njft (BESREMi) (PDF)  CP.PHAR.570  April 1, 2025
Rozanolixizumab-noli (Rystiggo) (PDF) CP.PHAR.648 March 1, 2025
Rucaparib (Rubraca®) (PDF) CP.PHAR.350 Retire by April 1, 2025
Rucaparib (Rubraca®) (PDF)  CP.PHAR.350  April 1, 2025
Rufinamide (Banzel) (PDF) CP.PMN.157 January 1, 2025
Ruxolitinib (Jakafi) (PDF) CP.PHAR.98 Retire by April 1, 2025
Ruxolitinib (Jakafi) (PDF)  CP.PHAR.98  April 1, 2025
Sacituzumab Govitecan-hziy (Trodelvy) (PDF) CP.PHAR.475 Retire by June 1, 2025
Sacituzumab Govitecan-hziy (Trodelvy) (PDF)  CP.PHAR.475  June 1, 2025
Sacubitril/Valsartan (Entresto) (PDF) CP.PCH.52 Retire by April 1, 2025
Sacubitril/Valsartan (Entresto) (PDF)  CP.PCH.52  April 1, 2025
Safinamide (Xadago) (PDF) CP.PMN.113 Retire by April 1, 2025
Safinamide (Xadago) (PDF)  CP.PMN.113  April 1, 2025
Sapropterin (Kuvan) (PDF) CP.PHAR.43 January 1, 2025
Sarecycline (Seysara) (PDF) CP.PMN.189 Retire by April 1, 2025
Sarecycline (Seysara) (PDF)  CP.PMN.189  April 1, 2025
Sargramostim (Leukine) (PDF) CP.PHAR.295 October 1, 2024
Satralizumab-mwge (Enspryng) (PDF)  CP.PHAR.463 October 1, 2024
Sebelipase Alfa (Kanuma) (PDF) CP.PHAR.159 June 1, 2024
Secnidazole (Solosec) (PDF) CP.PMN.103 Retire by April 1, 2025
Secnidazole (Solosec) (PDF)  CP.PMN.103  April 1, 2025
Seladelpar (Livdelzi) (PDF) CP.PHAR.698 January 1, 2025
Selexipag (Uptravi®) (PDF) CP.PHAR.196 Retire by April 1, 2025
Selexipag (Uptravi®) (PDF)  CP.PHAR.196  April 1, 2025
Selinexor (Xpovio) (PDF) CP.PHAR.431 January 1, 2025
Selpercatinib (Retevmo) (PDF) CP.PHAR.478 January 1, 2025
Selumetinib (Koselugo) (PDF) CP.PHAR.464 Retire by June 1, 2025
Selumetinib (Koselugo) (PDF)  CP.PHAR.464  June 1, 2025
Semaglutide (Wegovy) (PDF) CP.PMN.295 January 1, 2025
Sepsis Diagnosis (PDF) CC.PP.073 November 1, 2024
Setmelanotide (Imcivree) (PDF) CP.PHAR.491 Retire by April 1, 2025
Setmelanotide (Imcivree) (PDF)  CP.PHAR.491  April 1, 2025
Short ragweed pollen allergen extract (Ragwitek) (PDF) CP.PMN.83 January 1, 2025
Sildenafil (Revatio®) (PDF) CP.PHAR.197 Retire by April 1, 2025
Sildenafil (Revatio®) (PDF)  CP.PHAR.197  April 1, 2025
Sildenafil (Viagra) (PDF) CP.PCH.07 January 1, 2025
Siltuximab (Sylvant) (PDF) CP.PHAR.329 Retire by April 1, 2025
Siltuximab (Sylvant) (PDF)  CP.PHAR.329  April 1, 2025
Siponimod (Mayzent) (PDF) CP.PHAR.427 January 1, 2025
Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF) CP.PHAR.574 Retire by April 1, 2025
Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF)   CP.PHAR.574  April 1, 2025
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF) CP.PMN.42 January 1, 2025
Sodium Phenylbutyrate (Buphenyl) (PDF) CP.PHAR.208 Retire by April 1, 2025
Sodium Phenylbutyrate (Buphenyl) (PDF)  CP.PHAR.208  April 1, 2025
Sodium Phenylbutyrate-Taurursodiol (Relyvrio) 10.06.22.docx CP.PHAR.584 January 1, 2025
Sodium thiosulfate (Pedmark) (PDF) CP.PHAR.610 Retire by April 1, 2025
Sodium thiosulfate (Pedmark) (PDF)  CP.PHAR.610  April 1, 2025
Sodium Zirconium Cyclosilicate (Lokelma) (PDF) CP.PMN.163 January 1, 2025
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF) HIM.PA.91 Retire by April 1, 2025
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF)  HIM.PA.91  April 1, 2025
Sofosbuvir (Sovaldi) (PDF) HIM.PA.SP2 January 1, 2025
Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF) HIM.PA.SP63 January 1, 2025
Solriamfetol (Sunosi) (PDF) CP.PMN.209 January 1, 2025
Sonidegib (Odomzo) (PDF) CP.PHAR.272 January 1, 2025
Sorafenib (Nexavar) (PDF) CP.PHAR.69 January 1, 2025
Sotatercept (ACE-011) (PDF) CP.PHAR.657 Retire by April 1, 2025
Sotatercept (ACE-011) (PDF)  CP.PHAR.657  April 1, 2025
Sotorasib (Lumakras) (PDF) CP.PHAR.549 January 1, 2025
Sparsentan (Filspari) (PDF) CP.PHAR.631 January 1, 2025
Spesolimab-sbzo (Spevigo) (PDF) CP.PHAR.606 August 1, 2024
Spinosad (Natroba) (PDF) HIM.PA.134 January 1, 2025
Step Therapy Criteria (PDF) HIM.PA.109 January 1, 2025
Stiripentol (Diacomit) (PDF) CP.PMN.184 January 1, 2025
Sunitinib (Sutent) (PDF) CP.PHAR.73 January 1, 2025
Sutimlimab-jome (Enjaymo) (PDF) CP.PHAR.503 June 1, 2024
Suvorexant (Belsomra®) (PDF) CP.PMN.109 January 1, 2025
Tadalafil (Adcirca®) (PDF) CP.PHAR.198 Retire by April 1, 2025
Tadalafil (Adcirca®) (PDF)  CP.PHAR.198  April 1, 2025
Tadalafil BHP - ED (Cialis) (PDF) CP.PMN.132 January 1, 2025
Tafamidis (Vyndaqel, Vyndamax) (PDF) CP.PHAR.432 Retire by June 1, 2025
Tafamidis (Vyndaqel, Vyndamax) (PDF)  CP.PHAR.432  June 1, 2025
Tafasitamab-cxix (Monjuvi) (PDF) CP.PHAR.508 March 1, 2024
Talazoparib (Talzenna)(PDF) CP.PHAR.409 Retire by April 1, 2025
Talazoparib (Talzenna)(PDF)  CP.PHAR.409  April 1, 2025
Taliglucerase Alfa (Elelyso) (PDF) CP.PHAR.157 June 1, 2024
Talimogene laherepvec (Imlygic) (PDF) CP.PHAR.542 September 1, 2024
Talquetamab-tgvs (Talvey) (PDF) CP.PHAR.649 March 1, 2025
Tapinarof (Vtama) (PDF) CP.PMN.283 Retire by April 1, 2025
Tapinarof (Vtama) (PDF)  CP.PMN.283  April 1, 2025
Tarlatamab-dlle (Imdelltra) (PDF) CP.PHAR.685 January 1, 2025
Tasimelteon (Hetlioz) (PDF) CP.PMN.104 Retire by April 1, 2025
Tasimelteon (Hetlioz) (PDF)  CP.PMN.104  April 1, 2025
Tavaborole (Kerydin®) (PDF) CP.PMN.105 Retire by April 1, 2025
Tavaborole (Kerydin®) (PDF)  CP.PMN.105  April 1, 2025
Tazarotene (Arazlo, Fabior, Tazorac) (PDF) CP.PMN.244 January 1, 2025
Tazemetostat (PDF) CP.PHAR.452 Retire by April 1, 2025
Tazemetostat (PDF)  CP.PHAR.452  April 1, 2025
Tebentafusp-tebn (Kimmtrak) (PDF) CP.PHAR.575 June 1, 2024
Teclistamab-cqyv (Tecvayli) (PDF) CP.PHAR.611 Retire by April 1, 2025
Teclistamab-cqyv (Tecvayli) (PDF)  CP.PHAR.611  April 1, 2025
Tedizolid (Sivextro) (PDF) CP.PMN.62 September 1, 2024
Teduglutide (Gattex) (PDF) CP.PHAR.114 Retire by April 1, 2025
Teduglutide (Gattex) (PDF)  CP.PHAR.114  April 1, 2025
Telotristat ethyl (Xermelo) (PDF) CP.PHAR.337 January 1, 2025
Temozolomide (Temodar) (PDF) CP.PHAR.77 May 1, 2024
Temsirolimus (Torisel) (PDF) CP.PHAR.324 January1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF) HIM.PA.174 Retire by June 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF)  HIM.PA.174  June 1, 2025
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF) CP.PMN.268 January 1, 2025
Teplizumab-mzwv (Tzield) (PDF) CP.PHAR.492 Retire by April 1, 2024
Teplizumab-mzwv (Tzield) (PDF)  CP.PHAR.492  April 1, 2025
Tepotinib (Tepmetko) (PDF) CP.PHAR.530 January 1, 2025
Teprotumumab (Tepezza) (PDF) CP.PHAR.465 Retire by April 1, 2025
Teprotumumab (Tepezza) (PDF)  CP.PHAR.465  April 1, 2025
Teriflunomide (Aubagio) (PDF) CP.PCH.40 January 1, 2025
Teriparatide (Forteo®) (PDF) CP.PHAR.188 Retire by April 1, 2025
Teriparatide (Forteo®) (PDF)  CP.PHAR.188  April 1, 2025
Tesamorelin (Egrifta) (PDF) CP.PHAR.109 January 1, 2025
Testosterone (Androderm) (PDF) HIM.PA.87 January 1, 2025
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF) CP.PHAR.354 January1, 2025
Tetrabenazine (Xenazine) (PDF) CP.PHAR.92 January 1, 2025
Tezacaftor-Ivacaftor (Symdeko) (PDF) CP.PHAR.377 January 1, 2025
Tezepelumab-ekko (Tezspire) (PDF) CP.PHAR.576 May 1, 2024
Thalidomide (Thalomid) (PDF) CP.PHAR.78 January 1, 2025
Thioguanine (Tabloid) (PDF) CP.PHAR.437 January 1, 2025
Thyrotropin alfa (Thyrogen) (PDF) CP.PHAR.95 September 1, 2024
Timothy grass pollen allergen extract (Grastek®) (PDF) CP.PMN.84 January 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF) CP.PCH.50 January 1, 2025
Tirzepatide (Zepbound) (PDF) CP.PMN.298 April 1, 2025
Tisagenlecleucel (Kymriah) (PDF) CP.PHAR.361 Retire by June 1, 2025
Tisagenlecleucel (Kymriah) (PDF)  CP.PHAR.361  June 1, 2025
Tislelizumab-jsgr (Tevimbra) (PDF) CP.PHAR.687 Retire by April 1, 2024
Tislelizumab-jsgr (Tevimbra) (PDF)  CP.PHAR.687  April 1, 2025
Tisotumab Vedotin-tftv (Tivdak) (PDF) CP.PHAR.561 March 1, 2025
Tivozanib (Fotivda) (PDF) CP.PHAR.538 January 1, 2025
Tobramycin (PDF) CP.PHAR.211 January 1, 2025
Tofersen (Qalsody) (PDF) CP.PHAR.591 January1, 2025
Tolvaptan (Jynarque) (PDF) CP.PHAR.27 January 1, 2025
Topical Acne Treatment (PDF) HIM.PA.71 January 1, 2025
Topical Immunomodulators (PDF) CP.PMN.107 Retire by April 1, 2025
Topical Immunomodulators (PDF)  CP.PMN.107  April 1, 2025
Topiramate ER (Qudexy XR, Trokendi XR (PDF) CP.PMN.281 January 1, 2025
Topotecan (Hycamtin) (PDF) CP.PHAR.64 July 1, 2024
Toripalimab (Loqtorzi) (PDF) CP.PHAR.668 Retire by April 1, 2025
Toripalimab (Loqtorzi) (PDF)  CP.PHAR.668  April 1, 2025
Tovorafenib (Ojemda) (PDF) CP.PHAR.686 January 1, 2025
Trabectedin (Yondelis) (PDF) CP.PHAR.204 Retire by April 1, 2025
Trabectedin (Yondelis) (PDF)  CP.PHAR.204  April 1, 2025
Tralokinumab-ldrm (Adbry) (PDF) CP.PHAR.577 January 1, 2025
Trametinib (Mekinist) (PDF) CP.PHAR.240 January 1, 2025
Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF) CP.PHAR.228 January 1, 2025
Travoprost (iDose TR) (PDF) CP.PHAR.672 Retire by April 1, 2025
Travoprost (iDose TR) (PDF)  CP.PHAR.672  April 1, 2025
Tremelimumab-actl (Imjudo) (PDF) CP.PHAR.612 Retire by June 1, 2025
Tremelimumab-actl (Imjudo) (PDF)  CP.PHAR.612  June 1, 2025
Treprostinil (Orenitram®, Remodulin®, Tyvaso®) (PDF) CP.PHAR.199 Retire by April 1, 2025
Treprostinil (Orenitram®, Remodulin®, Tyvaso®) (PDF)  CP.PHAR.199  April 1, 2025
Triamcinolone ER Injection (Zilretta) (PDF) CP.PHAR.371 Retire by June 1, 2025
Triamcinolone ER Injection (Zilretta) (PDF)  CP.PHAR.371  June 1, 2025
Triclabendazole (Egaten) (PDF) CP.PMN.207 January 1, 2025
Trientine (Syprine) (PDF) CP.PHAR.438 January 1, 2025
Trifarotene (Aklief) (PDF) CP.PMN.225 Retire by April 1, 2025
Trifarotene (Aklief) (PDF)  CP.PMN.225  April 1, 2025
Trifluridine/Tipiracil (Lonsurf) (PDF) CP.PHAR.383 January 1, 2025
Triheptanoin (Dojolvi) (PDF) CP.PHAR.509 January 1, 2025
Triptorelin Pamoate (Trelstar, Triptodur) (PDF) CP.PHAR.175 January 1, 2025
Trofinetide (Daybue) (PDF) CP.PHAR.600 January 1, 2025
Tucatinib (Tukysa) (PDF) CP.PHAR.497 January 1, 2025
Ublituximab-xiiy (Briumvi) (PDF) CP.PHAR.621 June 1, 2024
Ulcer Therapy Combinations (Omeclamox Pak, Pylera, Talicia)(PDF) CP.PMN.277 January 1, 2025
Umbralisib (Ukoniq) (PDF) CP.PHAR.531 January 1, 2025
Uridine acetate (Vistogard) (PDF) HIM.PA.SP55 January 1, 2025
Vadadustat (Vafseo) (PDF) CP.PHAR.677 January 1, 2025
Valbenazine (Ingrezza) (PDF) CP.PCH.48 January 1, 2025
Valganciclovir (Valcyte) (PDF) CP.PCH.06 Retire by April 1, 2025
Valganciclovir (Valcyte) (PDF)  CP.PCH.06  April 1, 2025
Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF) CP.PHAR.466 Retire by April 1, 2025
Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF)  CP.PHAR.466  April 1, 2025
Valrubicin (Valstar) (PDF) CP.PHAR.439 March 1, 2025
Vamorolone (Agamree) (PDF) CP.PHAR.659 Retire by April 1, 2025
Vamorolone (Agamree) (PDF)  CP.PHAR.659  April 1, 2025
Vandetanib (Caprelsa®) (PDF) CP.PHAR.80 Retire by April 1, 2025
Vandetanib (Caprelsa®) (PDF)  CP.PHAR.80  April 1, 2025
Varenicline (Tyrvaya) (PDF) CP.PMN.273 Retire by April 1, 2025
Varenicline (Tyrvaya) (PDF)  CP.PMN.273  April 1, 2025
Velaglucerase Alfa (VPRIV) (PDF) CP.PHAR.163 June 1, 2024
Velmanase Alfa-tycv (Lamzede) (PDF) CP.PHAR.601 June 1, 2024
Velpatasvir (Epclusa) (PDF) HIM.PA.SP1 January 1, 2025
Vemurafenib (Zelboraf®) (PDF) CP.PHAR.91 Retire by June 1, 2025
Vemurafenib (Zelboraf®) (PDF)  CP.PHAR.91  June 1, 2025
Venetoclax (Venclexta) (PDF) CP.PHAR.129 January 1, 2025
Verteporfin (Visudyne) (PDF) CP.PHAR.187 Retire by April 1, 2025
Verteporfin (Visudyne) (PDF)  CP.PHAR.187  April 1, 2025
Vestronidase Alfa-vjbk (Mepsevii) (PDF) CP.PHAR.374 July 1, 2024
Vigabatrin (Sabril) (PDF) CP.PHAR.169 January 1, 2025
Viloxazine (Qelbree) (PDF) CP.PMN.264 January 1, 2025
Viltolarsen (Viltepso) (PDF) CP.PHAR.484 Retire by April 1, 2025
Viltolarsen (Viltepso) (PDF)  CP.PHAR.484  April 1, 2025
Vismodegib (Erivedge) (PDF) CP.PHAR.273 January 1, 2025
Voclosporin (Lupkynis) (PDF) CP.PHAR.504 January 1, 2025
Vorapaxar (Zontivity) (PDF) HIM.PA.146 Retire by April 1, 2025
Vorapaxar (Zontivity) (PDF)  HIM.PA.146  April 1, 2025
Vorasidenib (Voranigo) (PDF) CP.PHAR.699 January 1, 2025
Voretigene Neparvovec-rzyl (Luxturna) (PDF) CP.PHAR.372 Retire by April 1, 2025
Voretigene Neparvovec-rzyl (Luxturna) (PDF)  CP.PHAR.372  April 1, 2025
Vorinostat (Zolinza) (PDF) CP.PHAR.83 January 1, 2025
Vortioxetine (Trintellix®) (PDF) CP.PMN.65 January 1, 2025
Vosoritide (Voxzogo) (PDF) CP.PHAR.525 April 1, 2025
Voxelotor (Oxbryta) (PDF) CP.PHAR.451 Retire by April 1, 2025
Voxelotor (Oxbryta) (PDF)  CP.PHAR.451  April 1, 2025
Vutrisiran (Amvuttra) CP.PHAR.550 January 1, 2025
Xanomeline-trospium chloride (Cobenfy) CP.PMN.299 April 1, 2025
Zanidatamab-hrii (Ziihera) (PDF) CP.PHAR.709 April 1, 2025
Zanubrutinib (Brukinsa) (PDF) CP.PHAR.467 Retire by June 1, 2025
Zanubrutinib (Brukinsa) (PDF)  CP.PHAR.467  June 1, 2025
Zavegepant (Zavzpret) (PDF) CP.PHAR.630 March 1, 2025
Zenocutuzumab-zbco (Bizengri) (PDF) CP.PHAR.713 April 1, 2025
Zilucoplan (RA101495) (PDF) CP.PHAR.616 Retire by June 1, 2025
Zilucoplan (RA101495) (PDF)  CP.PHAR.616  June 1, 2025
Ziv-aflibercept (Zaltrap) (PDF) CP.PHAR.325 January 1, 2025
Zolbetuximab-clzb (Vyloy) (PDF) CP.PHAR.705 January 1, 2025
Zoledronic Acid (Reclast) (PDF) CP.PHAR.59 Retire by June 1, 2025
Zoledronic Acid (Reclast) (PDF)  CP.PHAR.59  June 1, 2025
Zuranolone (Zurzuvae) (PDF) CP.PHAR.650 January 1, 2025